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1. Vitamin A supplementation of pregnant women leads to increased serum retinol 
concentrations of their newborn infants (this thesis). 
2. Further research should be directed towards improving growth during infancy rather 
than increasing birth weight of Indonesian infants. However, pregnancy should still be 
considered as a possible period for intervention (this thesis). 
3. The concern of possible toxicity of vitamin A during pregnancy is out of proportion 
to the lack of concern of the world-wide burden of vitamin A deficiency. 
4. The problem of stress perceived by women during pregnancy and thereafter needs 
more attention because of possible negative consequences for their infant's 
development. 
5. More recognition of the interaction of psychological and physiological problems by 
general practitioners would enhance human well-being and reduce the costs of health 
6. Research projects aimed at solving malnutrition in developing countries should be 
enriched with a national PhD fellow. Such a policy would lead to capacity building and 
more sustainable application of results. 
7. The perceived lack of culture in the Netherlands derives from the definition of culture 
applied. 
8. Als je oude koeien uit de sloot haalt, kunnen de kalfjes vers water drinken (after a 
Dutch saying). 
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Abstract 
The role of maternal nutrition in growth and health of Indonesian infants: 
a focus on vitamin A and iron. 
PhD thesis of Marjanka K. Schmidt, Division of Human Nutrition and Epidemiology, 
Wageningen University, The Netherlands, 17 December 2001. 
Nutrition during pregnancy is important for women's health, pregnancy outcome, and 
infant growth and health. The aim of the present study was to investigate whether weekly 
supplementation with iron and vitamin A of pregnant women improves growth and 
health, as indicated by reduced morbidity and improved mental and psychomotor 
development, of their infants. At ~18 weeks of pregnancy, women from 5 villages were 
randomly assigned on an individual basis to supervised, double-masked supplementation 
once weekly from enrolment until delivery. Supplementation comprised 120 mg iron as 
Fe 2 S0 4 and 500 ug folic acid with (n=121) or without (n=122) 4800 RE vitamin A. 
Pregnant women participating in the ongoing national iron supplementation programme 
and receiving i ron/ folic acid tablets through medical services were recruited at the same 
time from 4 neighbouring villages ('daily' group, n=123). Compliance with iron tablet 
intake in this group was expected to be very low. Newborn infants were followed up at 
least until 1 year of age. 
At ~4 months of age, infants in the weekly vitamin A plus iron group had 
significantly higher serum retinol concentrations than infants in the weekly iron group. 
However, in all groups >70% of the infants had serum retinol concentrations <0.70 
umol/L. Higher serum retinol levels were associated with better growth and nutritional 
status during the first 6 months of life. Iron status did not differ among groups, while 
29% of the infants had a haemoglobin concentration <100 g /L and only 3 infants had a 
serum ferritin concentration <12 ug/L. During the first year of life, anthropometric 
parameters, morbidity and mental and psychomotor development of infants, whose 
mothers were supplemented with vitamin A plus iron during pregnancy, did not differ 
from those whose mothers had received iron alone. In addition, none of the investigated 
parameters differed between the infants in the weekly iron supplementation group and 
infants in the 'daily' group. Growth faltering of infants started at 6 months of age and led 
to high prevalence of stunting (24%) and underweight (32%) at 12 months of age. Almost 
all infants were breast-fed during the whole follow up period. Neonatal weight and length, 
reflecting prenatal factors, were the strongest predictors of growth and nutritional status 
of infants at 12 months of age. In addition, maternal weight and height at ~18 weeks of 
pregnancy, housing, and postnatal variables such as intake of certain food groups and 
morbidity were predictors of growth and nutritional status of infants at 12 months of age. 
In conclusion, vitamin A supplementation in concurrence of iron supplementation of 
pregnant women does not improve growth or health of their infants. However, it 
improved vitamin A status of their infants at ~4 months of age. Considering the 
association between growth and vitamin A status, and the high prevalence of serum 
retinol levels <0.70 umol/L, vitamin A intake during infancy may need to be increased. 
However, in order to optimise nutritional status and growth of infants the whole life cycle 
should be considered. 
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Article 25 of the Universal Declaration of Human Rights 
1. Everyone has the right to a standard of living adequate for the health and well-being of 
himself and of his family, including food, clothing, housing and medical care and 
necessary social services, and the right to security in the event of unemployment, sickness, 
disability, widowhood, old age or other lack of livelihood in circumstances beyond his 
control. 
2. Motherhood and childhood are entided to special care and assistance. All children, 
whether born in or out of wedlock, shall enjoy the same social protection. 
1 
General Introduction 
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1 Infant nutrition and health 
1.1 The importance of pre- and postnatal nutrition 
Nutrition during pregnancy is important for women's health, pregnancy outcome, and 
infant growth and health [1,2]. Iron and marginal vitamin A deficiency during pregnancy 
and lactation is a common problem world-wide and specifically in Indonesia [3-8]. In 
South East Asia, including Indonesia, 40% of infants and children are stunted (linear 
growth retarded) and suffer from deficiencies of iron and vitamin A [3,4,9]. Stunting is 
defined as linear growth retardation as indicated by a height-for-age z-score less than —2 
SD below the median of a reference population of children exposed relatively litde to 
malnutrition or infection [10]. 
1.2 Infant growth and nutritional status 
Most growth faltering, as indicated by being underweight or stunted, occurs from birth 
until about 2 years of age and may already start during the gestation period [11,12]. Intra-
uterine growth retardation (being small for gestational age) is estimated to occur in 24% 
of newborn infants worldwide [13]. Because gestational age is difficult to assess accurately 
in field settings, low birth weight is often used as a proxy for intra-uterine growth 
retardation. Although some catch-up growth is possible, infants who are born too small 
or with low birth weight are at high risk of becoming stunted during subsequent phases of 
childhood [11,14,15]. Stunting indicates an important public health problem because of its 
association with impaired cognitive development [16,17], increased susceptibility to 
infection [18] and increased risk of mortality [19,20]. The long-term outcome of stunting 
includes increased risk for chronic disease [21] and elevated risk of poor reproductive 
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Figure 1.1 Nutrition throughout the life cycle (adapted from reference 4). 
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1.3 Aetiology of infant growth retardation 
Infant linear growth retardation is determined by factors during the gestation period as 
well as during the postnatal period. However the causes and the underlying biological 
explanations of infant stunting are poorly understood [22,23]. Genetic background plays a 
limited role in the prevalence of stunting [24]. This is illustrated in a study in Indonesian 
families of high socio-economic class, which shows that growth of pre-school children is 
equal to that of the American reference population [25]. Inadequate maternal nutrition 
during gestation may contribute to growth retardation of the foetus. In addition, infants 
may be born with low nutrient stores [12,26-28]. During the postnatal period, insufficient 
food intake, inadequate feeding practices and continued or repeated infections contribute 
to growth retardation [24,29,30]. In countries with a high prevalence of micronutrient 
deficiencies such as Indonesia, it may be that specific deficiencies such as those of vitamin 
A and iron contribute to growth retardation during the prenatal and postnatal period [11]. 
2 Prenatal nutrition 
2.1 T h e impact of maternal nutrient intake on pregnancy outcome 
Maternal weight before pregnancy and weight gain during pregnancy has been related to 
infant birth weight [1]. Reviews of studies directed at increasing energy and protein intake 
during pregnancy concluded that a balanced increase of energy and protein intake results 
in modest increases in maternal weight gain and foetal growth [26,31]. 'Balanced' was 
defined as a supplement in which protein provided <25% of the energy content. 
However protein supplementation during pregnancy did not show any benefit on infant 
birth weight or length [31]. Other trials that supplemented pregnant women with food 
together or not with micronutrients were not effective in preventing intra-uterine growth 
retardation [26]. One trial in Gambian women showed that supplementation with 
groundnut based biscuit and fortified tea during pregnancy increased birth weight, but 
only in the wet season [32]. Another trial in Colombian women showed that 
supplementation with food and micronutrients (mostly vitamin A and iron) during the 
third trimester of pregnancy improved weight gain of women but did not significantly 
improve infant birth weight [33]. A trial in Indonesian women showed that energy 
supplementation during the last trimester of pregnancy increased length and weight of 
their infants significantly from the third month of age and height throughout the first 5 
years of age, although birth weight was not increased [27]. Thus increasing energy or 
protein intake of pregnant women, especially in community settings where logistics, 
targeting and leakage are a problem, will have a small chance of increasing birth weight or 
reduce stunting in infants. 
2.2 Vitamin A 
2.2.1 The impact of maternal vitamin A status and intake on pregnancy outcome 
Vitamin A is an essential nutrient throughout the life cycle but most importandy during 
pregnancy and early childhood. Vitamin A is needed for proliferation and differentiation 
of cells and plays a role in the immune system. Vitamin A deficiency may result from 
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inadequate dietary intake or from losses or increased requirements during disease [34]. 
Most dietary vitamin A is obtained from animal products or by conversion in the body 
from provitamin A from green leafy vegetables and orange/yellow fruits. However 
bioconversion of provitamin A to retinol is much less than previously assumed and when 
needs are increased, it is impossible to acquire sufficient vitamin A through plant foods 
[35]. 
The role of retinoic acid, a metabolite of vitamin A, in embryonic growth and 
development has been demonstrated in animal studies [36-38]. A vitamin A-deficient diet 
during pregnancy has been shown to affect organ growth and development of rats [39]. In 
cross-sectional studies in humans, vitamin A deficiency during pregnancy has been 
associated with low birth weight [28]. Serum retinol concentrations in cord blood of 
newborn infants have been reported to be associated with birth weight, while infants with 
intra-uterine growth retardation have been shown to be at almost three times greater risk 
of having retinol concentrations <0.70 umol/L [40,41]. However, these studies cannot 
provide causal evidence for an impact of vitamin A on birth weight of infants. In 2 
intervention studies, supplementation with vitamin A during pregnancy has not been 
shown to improve birth weight [42,43]. However, one of these 2 studies had insufficient 
statistical power to detect differences in birth weight while the other study started 
supplementation only at 28 weeks of pregnancy, which may have been too late. A well-
designed trial in Nepal did not show an impact of vitamin A supplementation on infant 
mortality [44] while effects on infant birth weight or growth have not been reported. 
Women with low vitamin A status and intake during pregnancy have low retinol 
levels in breast milk, which may be insufficient for infants to build up their stores in the 
postnatal period [45,46]. Vitamin A supplementation during pregnancy reduces night 
blindness [47] and has been shown to reduce maternal mortality by 40% [48]. Night 
blindness during pregnancy has been found to be associated with infant mortality [49]. In 
conclusion, from animal studies it is clear that vitamin A has an important role in 
pregnancy outcome, however so far this has not been confirmed in human studies. It may 
be that improving vitamin A status of pregnant women will have less impact on birth 
weight than on vitamin A stores in the foetus and vitamin A concentrations in breast 
milk, which may affect growth and immunity during infancy. 
2.2.2 The impact of maternal vitamin A status and intake on vitamin A stores of 
the infant 
During pregnancy, vitamin A is transferred from mother to foetus across the placenta. 
This process involves retinol binding protein, but the exact mechanism is not yet known 
[36]. Vitamin A concentrations in serum of newborn infants are low, about half of those 
found in their mothers [37]. According to Underwood [50], vitamin A status of newborn 
infants is not correlated with that of their mothers, except at the extremes of deficiency or 
excess. However, in vitamin A sufficient and as well as in vitamin A deficient women, 
maternal vitamin A status during pregnancy has been shown to be associated with foetal 
liver and infants cord blood concentrations of vitamin A [51-53]. In addition, aborted 
foetuses of Indian mothers from a high-income group were found to have higher liver 
12 
I N T R O D U C T I O N 
retinol concentrations than those from a low-income group [51]. It also has been reported 
that, serum retinol binding protein concentrations and saturation (serum retinol 
concentrations/retinol binding protein concentrations) in cord blood of newborn, 
fullterm infants are positively correlated with these parameters in their mothers [54]. Two 
intervention studies assessed the impact of vitamin A supplementation on vitamin A 
levels in cord blood of infants. In one study, supplementation with 6000 IU Vitamin A 
together with iron for more than 12 weeks during pregnancy increased cord levels of 
vitamin A [42]. In another study, daily supplementation with 8000 IU vitamin A from 30 
weeks of gestation until term increased plasma retinol concentrations in the mother and 
in cord blood, although the increase in the latter was not significant [43]. A major 
constraint is that most studies, except for 2 [43,54], did not use HPLC for determination 
of retinol concentrations. Vitamin A supplementation of vitamin A-deficient pregnant 
women may lead to an increase of placental transfer of retinol to the foetus. However, 
whether vitamin A stores of the infant are increased through vitamin A supplementation 
during gestation cannot be concluded from the available evidence. 
2.3 Iron 
2.3.1 The impact of maternal iron status and intake on pregnancy outcome 
Although iron absorption increases with advancement of gestation [55,56], this is often 
insufficient to meet the demands for iron. As a result, pregnant women often become 
anaemic. In addition, iron deficiency may result from consumption of diets with 
insufficient iron, reduced dietary iron availability, and losses due to intestinal worm 
infestation [57]. Metabolism and bioavailability of iron has been reviewed extensively 
[58,59]. Daily iron supplementation is usually prescribed for iron deficient anaemic 
women and has been implemented in health care programmes in many countries 
including Indonesia. Unfortunately, these programmes have not been shown to be 
successful in reducing iron deficiency anaemia [60]. Folic acid is commonly included 
because folate deficiency is a common cause of megaloblastic anaemia [61]. Anaemia 
during pregnancy has been shown to be associated with low birth weight, premature 
delivery, and with perinatal and foetal death [62-65]. One study has shown that inadequate 
iron status during the first trimester of pregnancy is associated with low birth weight and 
preterm delivery [66]. Many other trials have also investigated the consequences of iron 
deficiency anaemia during pregnancy on pregnancy outcome but no firm conclusions can 
be drawn [28,67]. This is because many of the studies were poorly designed and because 
of the difficulty in interpreting haemoglobin concentrations during pregnancy. 
2.3.2 Relationship with infant iron status 
It is generally thought that maternal iron status during pregnancy has little influence on 
iron status of infants as indicated by haemoglobin concentrations or serum indicators of 
iron stores [68]. However there are reports that iron levels in cord blood and iron stores 
in infants of mothers with iron deficiency anaemia are reduced [69,70]. Thus, in iron-
deficient anaemic women, iron stores of infants may be affected by those of their mothers 
during pregnancy [71]. In a placebo-controlled study in Niger, iron supplementation 
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during pregnancy improved infant length at birth and serum ferritin concentration at 3 
months after birth [72], Sufficient iron status of infants at birth is very important as 
infants will deplete their iron stores during the first half year of life when rapid growth 
occurs. Iron intake from breast milk is low and may not be sufficient to support growth 
and building of iron stores [73]. Considering the evidence from the trial in Niger and 
associations found in other studies, it may well be that iron supplementatation of 
pregnant women can improve iron status of their infants at birth. 
3 Postnatal nutrition 
3.1 Nutrient intake 
Adequate energy and protein intakes of infants are important for their growth. Breast-
feeding is considered the optimal nutrition for infants up to 4-6 months of age [74] and 
decreases the risk of morbidity and mortality in infants in developing countries [75,76]. 
Moderate maternal malnutrition does not diminish the capacity to produce sufficient milk 
to sustain infant growth [77-79], However low levels of specific nutrients in breast milk 
might contribute to infant growth faltering [77]. After 6 months, growth of breast-fed 
infants may be limited by energy, protein or micronutrient content of complementary 
foods [74,80,81]. The highest impact of supplementation on growth of infants has been 
shown in periods of weaning or high incidence of diarrhoea [82]. However, intervention 
studies with supplements late in infancy have not shown sustainable effects on growth 
into childhood [83,84]. 
3.2 Vitamin A 
3.2.1 Vitamin A status and intake during infancy 
Colostrum and breast milk in the first week after delivery, are rich sources of vitamin A 
exceeding 3.5 )J,mol/L [37]. Feeding colostrum and this 'transitional' breast milk can 
therefore increase the neonatal body stores of vitamin A significandy [50]. In breast-fed 
infants, breast milk continues to be an importance source of vitamin A. However, if their 
mothers have poor vitamin A status, vitamin A levels in breast milk may be insufficient to 
build up their stores [46]. Breast milk concentrations of vitamin A have been found to be 
lower in developing than in developed countries [74], with the values from a study in 
West Java being among the lowest concentrations reported: 0.58-0.76 u,mol/L [85]. 
Therefore, vitamin A supplementation during lactation is recommended for improving 
maternal and infant vitamin A status in populations with vitamin A deficiency [86]. 
Indonesian women supplemented with 300000 IU vitamin A within 2 weeks after delivery 
had higher vitamin A concentrations in their milk up to 8 months after delivery compared 
with those who received placebo [6]. In addition, the proportion of infants with low 
serum retinol concentrations (<0.52 |0.mol/L) and low vitamin A stores at 6 months of 
age was lower in infants whose mothers were supplemented with vitamin A than in their 
counterparts whose mothers received placebo [6]. 
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3.2.2 Consequences of vitamin A deficiency 
Vitamin A plays an important role in immune function and vision, as severe deficiency 
inevitable leads to blindness [87,88]. Mild vitamin A deficiency in infants and children is 
associated with diarrhoea, respiratory infections and measles [89,90]. In populations 
where vitamin A deficiency is prevalent, vitamin A supplementation can reduce mortality 
and morbidity in children aged 6 months until 5 years of age [91]. Vitamin A 
supplementation to mothers during lactation has been shown to reduce morbidity of 
infants through increased intake of vitamin A via breast milk [6,92,93]. It should be noted 
that such effects have not been shown in infants younger than 6 months of age [94-96]. 
As reviewed before [83], vitamin A supplementation has not been shown to improve 
growth in many studies. However vitamin A supplementation has been shown to improve 
growth of children with vitamin A deficiency as indicated by low serum retinol 
concentrations or xerophthalmia [97-100]. Hence, vitamin A clearly plays an important 
role in growth and morbidity of infants, although the impact on young infants is not yet 
clear. 
3.3 Iron 
3.3.1 Iron status and intake during infancy 
Circumstances around the time of delivery, e.g. early or late clamping of the cord, and 
foetal blood loss into the placenta or mother, may affect neonatal iron status [73,101]. 
Haemoglobin concentrations are particularly high at birth, reflecting the oxygen-poor 
environment in the uterus, and decrease thereafter before stabilising at about 3 months of 
age. During that same period serum ferritin levels increase, reflecting increased iron stores 
in the liver cells [73]. Birth weight, the rate of growth and iron stores at birth are major 
influences on iron status during infancy [68,73,102]. Bioavailability of iron in human 
breast milk is high, but concentrations are low and fall during lactation from about 0.6 
mg/L at 2 weeks to 0.4 mg/L at 6-8 weeks and 0.3 mg/L at 3-5 months [73]. Iron levels 
in breast milk seem to be relatively unaffected by food intake, iron supplements or iron 
status [103,104]. Full term, breast-fed infants normally do not require additional sources 
of iron in the diet until 6 months of age [104,105]. However after 6 months of age, if iron 
from complementary foods is insufficient, infants may develop iron deficiency anaemia 
[73,105]. 
3.3.2 Consequences of iron deficiency 
Iron is needed for a wide range of metabolic activities and is essential for growth. Iron 
deficiency has been found to have a negative impact on immunity [106] and is associated 
with decreased growth rate and increased morbidity in children [83,107-110]. Iron 
supplementation has been shown to improve growth of anaemic pre-school and school 
children in 2 studies in Indonesia [107,108]. During infancy and childhood, iron 
deficiency anaemia leads to impaired mental and motor development with possible long 
term consequences [111-113]. 
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4 Other factors in infant nutrition and health 
Many other factors, including sanitation, clean water, time for child care, access to health 
services and dietary factors, can play a role in pregnancy outcome and growth of infants 
[28,114]. Feeding practices, i.e. timely introduction of complementary food, the duration 
of breast feeding and type of food, but also feeding behaviour and feeding style may 
affect infants growth [74,115]. Infection can affect nutrition through anorexia, impaired 
nutrient absorption, losses of micronutrients in urine, increased metabolism or impaired 
transport to target tissues [116,117]. The severity of the impact of morbidity on growth 
differs among age groups and populations [83,116]. Studies in The Gambia and 
Bangladesh, for example, have shown that lower respiratory tract infections, diarrhoea 
and gastro-enteritis were associated with a reduction in growth [118-120]. Thus infections 
may limit growth in infants and children, however breast-feeding may play a protective 
role [24,120]. 
5 Interaction between vitamin A and iron 
Vitamin A is known to play a role in iron metabolism and it has been suggested that 
vitamin A deficiency impairs erythropoiesis and mobilisation of iron from body stores 
into the circulation [121]. In marginally vitamin A deficient rats, supplementation with 
iron and vitamin A was more effective in restoring normal iron status than was iron 
supplementation alone [122]. An observational study in children showed a positive 
association of serum retinol concentrations with those of serum iron, ferritin and 
transferrin [123]. Supplementation with vitamin A in children increased haemoglobin 
concentrations, serum iron concentrations and of transferrin saturation but did not affect 
serum ferritin concentrations [124,125]. In pregnant Indonesian women who were 
anaemic, daily supplementation with vitamin A and iron increased haemoglobin 
concentrations levels about 12 g /L of which one third could be attributed to vitamin A 
[126]. 
6 Study rationale 
A large proportion of Indonesian infants suffer from nutritional deficiencies and growth 
retardation while deficiencies of iron and vitamin A especially are highly prevalent in 
pregnant and lactating Indonesian women. There is evidence for a role of maternal 
nutrition during pregnancy in infant birth weight and subsequent growth. Vitamin A 
status during pregnancy has been shown to affect vitamin A levels in breast milk and 
possibly vitamin A stores of infants. Anaemia and possibly iron deficiency during 
pregnancy have been associated with negative pregnancy outcomes, although strong 
evidence is lacking. Both iron and vitamin A are important nutrients in growth and 
immunity and have been shown to improve growth in some studies, while vitamin A has 
been shown to reduce mortality and morbidity in infants. Vitamin A plays a role in iron 
metabolism and has been shown to reduce anaemia in vitamin A deficient pregnant 
women. Thus, we hypothesised that growth retardation of the foetus in utero and of the 
16 
I N T R O D U C T I O N 
infant postnatally may be prevented by improving the iron and vitamin A status of their 
mothers during pregnancy. 
7 Research objectives (outline of the thesis) 
The following research questions have been addressed and are described in the thesis. 
• To investigate the effect of supplementation with vitamin A and iron during 
pregnancy on infant vitamin A and iron status (Chapter 2). 
• To investigate the effect of weekly supplementation with vitamin A plus iron 
compared to iron alone during pregnancy on growth performance, nutritional 
status and morbidity of infants during the first year of life (Chapter 3). 
• To investigate patterns and determinants of growth of infants during the first year 
of life (Chapter 4). 
• To investigate the effect of supplementation with vitamin A and iron during 
pregnancy on mental and psychomotor development of infants (Chapter 5). 
Chapter 6 consists of a general discussion and conclusions of all results described in this 
thesis. The methodological aspects of the study, general conclusions, implications for 
health policy and programmes and future research written joindy with Siti Muslimatun are 
also presented in Chapter 6. 
8 Study site and design 
From November 1997 until November 1999, a community-based study was carried out in 
9 rural villages in Leuwiliang, a rural area in West Java, Indonesia. Indonesia has a 
population of 207 million and infant mortality rate is 43 per 1000 live births [127]. 
Leuwiliang, one of the subdistricts of Bogor, has about 140000 inhabitants, measures 158 
km2 and is situated 26 km from Bogor centre. It has 19 villages and most of the villages 
are situated on an altitude of 500-700 m. The average number of persons per household 
was 5 [128]. The maximum distance between study villages was 20 km. Only the main 
road had asphalt, the remaining roads were made from stone or soil. 
For the study, 3 groups of women were recruited at approximately 18 weeks of 
pregnancy. Women from 5 villages were assigned randomly to 2 groups on an individual 
basis to receive weekly supplementation from enrolment until delivery. Supplementation 
comprised 2 tablets each containing 60 mg elemental iron as ferrous sulfate and 250 ug 
folic acid with or without 2400 retinol equivalent (RE) vitamin A. This amount was below 
the safe level of intake of 7500 RE vitamin A during pregnancy [129]. As advised by the 
Indonesian Ministry of Health, based on the RDA of vitamin A for Indonesian pregnant 
women (700 RE) and the expected absorption and dietary intake of vitamin A, we 
intended to supplement 6000 RE weekly (3000 RE per tablet). However, analysis of the 
supplements ~1 year after production, revealed that the tablets contained —2400 RE; thus 
we considered to have given 4800 RE weekly. Both types of supplements were similar in 
physical appearance. The pregnant women received the supplement once a week between 
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09.00 and 12.00 h from voluntary health workers who ensured that the women swallowed 
the tablets in their presence. 
Subjects from the other 4 villages were assigned to a third group, referred to as the 
'daily' group. These subjects were participating in the ongoing national supplementation 
programme and received iron plus folic acid tablets through medical services. This 
programme has been implemented since 1970 [130]. It would therefore have been 
unethical to include an iron placebo group in the present study. However, compliance was 
expected to be low [131] thus this group was included as a 'control' group for comparison 
with the weekly iron supplementation group. We recruited this group from different 
villages in order to avoid confusion about the iron tablets among midwives, voluntary 
health workers and other persons involved in the research. Following government 
guidelines, women start receiving supplementation during their first visit for antenatal 
care at the Posyandu (integrated health services post) and should receive 90-120 iron plus 
folic acid tablets, each tablet containing 60 mg elemental iron and 250 (Xg folic acid, to be 
taken daily throughout pregnancy. These tablets were similar in appearance to the tablets 
administered weekly. By including this 'daily' group, the study also intended to test the 
hypothesis that iron supplementation once a week instead of daily would be a method of 
choice for reducing iron deficiency anaemia in pregnant women [132,133]. The theory 
behind this was that intermittent iron supplementation would avoid the postulated 
mucosal block of iron absorption [134] and would have the advantage of higher 
compliance due to decreased side effects [133,135], easier distribution and lower costs. In 
addition, previous studies had shown that weekly iron supplementation had similar effects 
on iron status as daily iron supplementation [136-138]. 
For the pregnant women, a sample size of 63 per group was calculated based on 5% 
significance level (two-tailed test), power of 80%, difference in haemoglobin 
concentration of 5 g /L and standard deviation of 10 g/L. For the infants, a sample size of 
51 per group was based on 5% significance level (two-tailed test), power of 80%, 
difference in length at 1 year of age of 1.5 cm and standard deviation of 2.7 cm. A sample 
size of 120 women per group was chosen to allow for a 50% drop out during pregnancy 
and during follow-up period until their infants reached 1 year of age. 
In addition to this thesis, another thesis entitled 'Nutrition of Indonesian women during 
pregnancy and lactation: a focus on vitamin A and iron' by Siti Muslimatun is based on 
the described study. 
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Vitamin A and iron supplementation of Indonesian 
pregnant women benefits vitamin A status of their 
infants 
Marjanka K. Schmidt, Siti Muslimatun, Clive E. West, Werner Schultink and Joseph 
G.AJ. Hautvast 
ABSTRACT Many Indonesian infants have an inadequate nutritional status, which may 
be due in part to inadequate maternal nutrition during pregnancy. This study was designed 
to investigate whether infant nutritional status can be improved by vitamin A and iron 
supplementation during gestation. Mothers of these infants from 5 villages had been 
randomly assigned on an individual basis to supervised, double blind supplementation 
once weekly from ~18 weeks of pregnancy until delivery. Supplementation comprised 120 
mg iron and 500 ug folic acid with or without 4800 retinol equivalent vitamin A. Mothers 
of infants from 4 other villages who participated in the national iron/folk acid 
supplementation programme were also recruited; intake of tablets was not supervised. 
Anthropometric and biochemical parameters of infants and their mothers were assessed 
~4 months after delivery. Infants of mothers supplemented with vitamin A plus iron had 
higher serum retinol concentrations than infants of mothers supplemented with iron 
alone. However the proportion of infants with serum retinol concentrations <0.70 
umol/L was >70% in all groups. Maternal and infant serum retinol concentrations were 
correlated. Iron status, weight and length of infants were similar in all groups. Iron status 
of girls was better than that of boys, but boys were heavier and longer. We conclude that 
supplementation with vitamin A in conjunction with iron supplementation of women 
during pregnancy benefits vitamin A status of their infants. However considering the large 
proportion of infants with marginal serum retinol concentrations it may still be necessary 
to increase their vitamin A intake. 
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In Indonesia many infants have an inadequate nutritional status as shown by the high 
prevalence of micronutrient deficiencies, underweight and stunting [1]. Low nutrient 
stores and growth retardation of infants may partly be caused by inadequate nutrition of 
their mothers during pregnancy [2,3]. A large proportion of Indonesian pregnant women 
suffer from iron deficiency anaemia and marginal vitamin A deficiency [1,4,5]. 
Adequate maternal vitamin A status during pregnancy is important for the 
development of the foetus and sufficient levels of vitamin A in breast milk [6]. The 
relationship between vitamin A status of pregnant women and that of their newborn 
infants is indicated by associations of serum retinol levels during pregnancy with foetal 
liver retinol concentrations and by a high correlation of vitamin A concentrations in cord 
and maternal serum [7,8]. In addition vitamin A supplementation of pregnant women has 
been shown to increase cord levels of vitamin A [9], Vitamin A intake and status in the 
third trimester of pregnancy have been found to affect concentrations of vitamin A in 
breast milk [10]. 
Iron deficiency anaemia during pregnancy is associated with higher risk of low birth 
weight and preterm delivery [11]. In addition evidence is accumulating that maternal iron 
deficiency in pregnancy reduces foetal iron stores and this may influence development 
during the postnatal period [12]. In a placebo-controlled study in Niger, iron 
supplementation during pregnancy improved infant length and APGAR scores at birth, 
and serum ferritin concentration 3 months after birth [13]. Under conditions of poor diet 
quality, iron alone may not be effective in correcting iron deficiency anaemia during 
pregnancy [14]. Vitamin A supplementation has been found to improve haemoglobin 
concentrations of pregnant women [9,15] and vitamin A plus iron supplementation to 
benefit iron status of children [16]. Roodenburg et al. [17] confirmed the benefit of 
vitamin A for iron status in a study in rats and suggested that mobilisation of iron was 
improved by vitamin A supplementation. 
In Indonesia iron supplementation during pregnancy is standard practice and 
therefore it is not ethical to conduct a study in which pregnant women are not provided 
with iron [14]. However compliance in the governmental programme is low and we found 
that supervised weekly iron supplementation performed similarly to the ongoing iron 
supplementation programme with respect to improving maternal iron status during 
pregnancy [18]. Considering the adverse effects of iron deficiency on mental and motor 
development of infants [19] it is important to assess the impact of any new iron 
supplementation regime on infant iron status. 
We hypothesised that improving the vitamin A and iron status of pregnant women 
may also lead to an improvement in iron status, vitamin A status, length and weight of 
their infants after birth. The present study was designed to investigate whether infant 
nutritional status can be improved by weekly supplementation of their mothers during 
pregnancy with vitamin A and iron. 
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Materials and methods 
Study design 
The present study was carried out in infants from 9 rural villages in Leuwiliang subdistrict, 
Bogor district, West Java, Indonesia. Mothers of these infants had been supplemented 
with iron and folic acid, either with or without vitamin A, during pregnancy or had access 
to iron/folic acid tablets through the ongoing government programme. Explanation of 
the study had been given to the women at enrolment and only women who gave written 
informed consent participated. The research proposal was approved by the Ministry of 
Health Indonesia and the Ethical Committees of the Medical Faculty at the University of 
Indonesia and Wageningen University. 
Initially 366 women were enrolled to participate in the study (Figure 2.1). A sample 
size of 120 women per group had been chosen to allow for 50% drop-out during the 
study period [18]. The present article reports the effect of supplementation on the 
nutritional status of infants at ~4 months of age. The results of the effect of 
supplementation with iron and vitamin A during pregnancy on biochemical status near 
term, including details of the study design, have been published elsewhere [18]. Briefly, 
women, who were 16-20 weeks pregnant, aged 17-35 years and parity <6, from 5 villages 
were randomly assigned on an individual basis to double-blind, weekly supplementation 
until delivery. Supplementation consisted of 2 tablets each containing 60 mg iron as 
ferrous sulphate and 250 ug folic acid with or without 2400 retinol equivalent (RE) 
vitamin A. W H O guidelines [20] allow a maximum weekly dose of 7500 RE. The 
intention was to supplement pregnant women with 6000 RE per week, based on advice of 
the Indonesian Ministry of Health. However owing to losses during storage vitamin A 
supplementation was found to be 4800 RE weekly. Tablet intake was supervised by 
volunteer health workers and monitored by field assistants. Health personnel and 
participants received clear instructions in order to avoid additional iron tablet intake. The 
average period of supplementation in these 'weekly' groups was 20 weeks; thus mothers 
had taken about 40 tablets. Women from the other 4 villages, referred to as the 'daily' 
group, were recruited at the same time. These women had free access to iron tablets from 
the health care services following government policy that pregnant women should receive 
90-120 iron/folk acid tablets, containing 60 mg iron as ferrous sulphate and 250 ug folic 
acid. Tablet intake in this group was not supervised because this was an effectiveness trial 
comparing the weekly, supervised iron supplementation to the current programme. 
Adherence of tablet intake was assessed though interview during a postnatal home visit 
which revealed that the median tablet intake was 50 while only 17% of the subjects took 
>90 tablets [18]. 
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nearest 0.1 cm by using a plastic measuring tape. At enrolment, height of mothers had 
been measured to the nearest 0.1 cm using a standing height measurement microtoise. 
Infant health 
Physicians from the community health centre (Puskesmas) examined the general health of 
the infants before blood sampling. Signs and symptoms examined were: running nose, 
fever, cough, upper respiratory tract infection, diarrhoea, skin disease such as diaper rash 
and dermatitis, and ear discharge. Besides the individual categories, the term 'sick' was 
defined as having at least 1 of the signs or symptoms mentioned above. Medical treatment 
was provided when necessary. At the time of the anthropometric assessment, the field 
assistants interviewed the mothers to assess whether they were still breast-feeding. 
Data an 
Normality of data distribution was checked by visual evaluation using a histogram with a 
normal curve. Serum ferritin and sTfR concentrations were not normally distributed; 
therefore these data were logarithmically transformed and reported as mean with 95% CI. 
In the analyses the weekly vitamin A plus iron group was compared with the weekly iron 
group to evaluate the effect of vitamin A supplementation. In addition, the weekly iron 
group was compared to the 'daily' group to evaluate the different iron supplementation 
regimes. Differences in age, anthropometric and biochemical variables between groups 
were evaluated by independent /-test. ANOVA was used to evaluate differences between 
groups or genders correcting for gender or group and age. Differences in proportions 
were evaluated by %2-test. Trends in biochemical variables of infants by age were evaluated 
using linear regression. Association of parameters of biochemical status within infants and 
between infants and their mothers was estimated by the Pearson correlation coefficient. 
To establish the determinants of infant serum ferritin and retinol concentrations stepwise 
multiple linear regression was applied. Because the weekly iron and 'daily' groups did not 
differ with respect to anthropometric and biochemical variables, groups were defined as 
vitamin A supplementation (1) or not (0), i.e. weekly vitamin A plus iron group, 1; weekly 
iron group, 0; 'daily' group, 0. Results did not change if we included the 3 groups as 2 
dummy variables. Initially, variables of mothers during pregnancy, mothers at ~4 months 
postpartum and infants were included in the model. However, analysis revealed that 
association between maternal variables during pregnancy and infant variables were poor. 
Therefore, it was decided to include only variables of mothers at ~4 months postpartum 
and infants in the model. Variables of infants included in both models were age at the 
time of blood collection, gender, neonatal weight, weight at ~4 months of age, and 
haemoglobin, serum ferritin, serum sTfR and serum retinol concentrations. Variables of 
mothers included in both models were haemoglobin, serum ferritin, serum sTfR and 
serum retinol concentrations, and weight ~4 months postpartum and height. Prevalence 
of upper respiratory infection was included in the model for serum retinol concentrations. 
Neonatal length and length at ~4 months of age were not included in the model because 
they were highly correlated with neonatal weight and weight at ~4 months of age 
respectively (r >0.8). Also, maternal mid-upper arm circumference was not included 
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because it was highly correlated with maternal weight ~4 months postpartum (r >0.8). 
Variables that were found to be significandy associated with the dependent variable in the 
stepwise multiple regression analysis were entered again in a model for each dependent 
variable and are presented. The SPSS software package (Windows version 7.5.2. SPSS 
Inc., Chicago, IL, USA) was used for all statistical analyses and a P value of <0.05 was 
considered as significant. 
Results 
Women were recruited in 6 rounds from November 1997 until May 1998, and blood 
samples for the postpartum assessment were taken between August 1998 and February 
1999. From enrolment during pregnancy until ~4 months after delivery [3.7 (1.9-6.3) 
months; mean (range)] 22 (18%), 20 (17%) and 20 (16%) mothers and infants dropped 
out in the weekly vitamin A and iron group, weekly iron group and 'daily' group 
respectively. Drop-out did not differ among groups and was not related to gender of the 
infants. Of the infants eligible for the assessment at ~4 months of age, 28 (28%), 25 
(25%) and 29 (28%) in the weekly vitamin A and iron, weekly iron and 'daily' groups 
respectively did not provide a blood sample or did not attend the assessment. We present 
data of infants (n=222) from whom sufficient blood was drawn for the assessment of 
haemoglobin concentration, and their mothers (Figure 2.1). Age, parity, anthropometric 
and biochemical variables of mothers and gender and anthropometric variables of infants 
either at the postnatal visit (measured n=326) or at ~4 months of age (measured n=276) 
did not significantly differ (corrected for age) between subjects included or excluded (data 
not shown). However, infants for whom data are reported had higher neonatal length than 
infants for whom data are not reported (49.6 ± 0.2 cm, n=222 versus 48.9 ± 0.2 cm, n=80; 
P <0.05; mean ± SE). 
Age and gender of infants was similar in all groups (Table 2.1). Infants in the weekly 
vitamin A plus iron group had higher serum retinol concentrations than the infants in the 
weekly iron group (Table 2.1). Serum retinol concentrations did not differ between the 
weekly iron and 'daily' group. The proportion of infants with a serum retinol 
concentration <0.35 umol/L was 3%, 11%, 20% and with a serum retinol concentration 
<0.70 (Xmol/L was 71%, 84% and 78% in the weekly vitamin A and iron, weekly iron and 
'daily' groups respectively. 
Iron status, length and weight of infants did not differ between the weekly groups or 
between the weekly iron group and the 'daily' group (Table 2.1). The proportion of 
infants with a haemoglobin concentration <100 g /L and <110 g /L was similar in all 
groups, 29% and 68% respectively while the lowest value was 83 g/L. Only 3 infants had 
a serum ferritin concentration <12 ug/L. Serum ferritin and sTfR concentrations of 
infants were inversely correlated (r =-0.420, P <0.01) in all groups. Iron status and serum 
retinol concentrations of mothers and infants did not differ between mothers in the 'daily' 
group who had taken less than 50 tablets and those who had taken more than 50 tablets 
during pregnancy. 
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Serum ferritin concentrations decreased (Figure 2.2) while haemoglobin (r =0.173) 
and serum sTfR concentrations (r =0.293) increased significantly (P <0.01) with age. 
Serum retinol concentrations did not change with age. Girls had a better iron status, 
defined by higher serum ferritin and lower serum sTfR concentrations, than boys. 
However boys had a higher serum retinol concentration and were longer and heavier than 
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Age, months 
Figure 2.2 Relationship between serum ferritin concentration and age of infants 
(r =-0.520, P <0.01). 
At ~4 months postpartum, iron status, serum retinol concentration and 
anthropometric variables of mothers did not differ between the weekly groups or between 
the weekly iron group and the 'daily' group (Table 2.2). At ~4 months postpartum serum 
retinol concentrations of mothers and infants were correlated (r =0.374, P <0.01) in all 
groups. Haemoglobin concentrations of mothers and infants were positively correlated 
(r =0.248, P <0.01), but if evaluated per group only reached significance in the weekly 
iron and vitamin A group and the 'daily' group. 
Maternal serum retinol concentrations at enrolment and infant serum retinol 
concentrations were positively correlated in the vitamin A and iron group, weekly iron 
group and the 'daily' group (r =0.127, not significant; r =0.288, P <0.05; and r =0.438, 
P <0.01 respectively). None of the variables of iron status of mothers during pregnancy 
was correlated with infant nutritional status. Also when comparing anaemic (haemoglobin 
concentration <110 g/L) with non-anaemic mothers or comparing mothers with serum 
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ferritin concentration <12 |J.g/L with those >12 H-g/L, no differences in nutritional status 
of infants were found. 
Table 2.2 Biochemical and anthropometric characteristics of mothers at ~4 months 
postpartum who had been supplemented with 2 tablets weekly each containing 60 mg 
ferrous sulfate and 250 ug folic acid with or without 2400 retinol equivalent vitamin A. 




Serum ferritin,3 /ug/L 
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JData are presented as mean with SE or geometric mean with 95% confidence interval; 
sTfR, soluble transferrin receptor; MUAC, mid-upper arm circumference; 2n=71, 74, 74; 
3n=71, 75, 73; 4n=69, 74, 73; 5n=71, 73, 71. 
Neonatal weight and length of infants were similar in all groups, 3.18 ± 0.50 kg (mean 
± SD) and 49.6 ± 2.3 cm respectively. The time between birth and measurement of 
neonatal weight and length (7.3 ± 6.3 days) varied largely due to inadequate 
communication and difficulty in reaching the subjects. Only 20% of the infants were 
reached within 72 hours, measuring 3.01 kg and 48.6 cm, and 63% were reached within 7 
days, measuring 3.07 kg and 49.0 cm. 
A general health check was obtained from 217 of the 222 infants. Data could not be 
obtained from 5 infants because of the temporary absence of the physician. The 
proportion of infants with various signs and symptoms of disease were: running nose, 
36%; fever, 7%; cough, 8%; upper respiratory tract infection, 5%; diarrhoea, 4%; skin 
diseases such as diaper rash and dermatitis, 24%; ear discharge, 2%; and sick (by definition 
having 1 or more sign or symptom of disease), 56%. Prevalence of these signs and 
symptoms and the proportion sick were similar in all groups. The serum retinol 
concentration of infants with upper respiratory tract infection (0.42 ± 0.04 (Xmol/L; 
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mean ± SE; n = l l ) was lower (P <0.01) than that of infants without (0.58 ± 0.01 (Xmol/L; 
n=167). In fact all infants with upper respiratory tract infection had a serum retinol 
concentration <0.70 |J.mol/L. Haemoglobin concentrations were consistently lower in 
infants with running nose, fever, cough, upper respiratory tract infection, diarrhoea, skin 
diseases and ear discharge. Infants defined as sick had a haemoglobin concentration 
3.3 g /L less than their healthy counterparts (P <0.01; corrected for age). Serum sTfR and 
ferritin concentrations did not significandy differ between infants with or without any sign 
or symptom, after correction for sex and age, except that infants with skin diseases had 
higher (P <0.05) serum ferritin concentrations [(89.4 (71.3-112.1), geometric mean (95% 
CI)] than those without [68.7 (60.5-78.0)]. 
Table 2.3 Determinants of serum ferritin and retinol concentrations in infants from all 
groups at ~4 months of age1 
Coefficient (b) SE P R2 
value 
Serum ferritin concentration2, jug/L (n= 172) 0.466 
Age of infant at blood drawing, months 
Neonatal weight, kg 
Gender (boy=0, girl=l) 
Serum sTfR concentration of infant2, mg/L 
Haemoglobin concentration of infant, g/L 
Height of mother, cm 
Serum retinol concentration, fimol/L (n=168) 0.351 
Serum retinol concentration of mother, fimol/L 
Upper respiratory tract infection (not present=0, 
present=l) 
Vitamin A supplementation (no vitamin A=0, 
vitamin A=l ) 
Haemoglobin concentration of infant, g/L 
Infant weight ~4 months of age, kg 
Serum sTfR concentration of infant2, mg/L 
Stepwise multiple regression analysis; biochemical variables of mothers and infants were 
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Determinants of serum retinol and ferritin concentrations in infants were evaluated by 
multiple regression analysis and are presented in Table 2.3. Age, neonatal weight and 
gender were found to be the strongest determinants of serum ferritin concentrations. 
Serum retinol concentrations of mothers ~4 months postpartum, upper respiratory tract 
infection and vitamin A supplementation showed the strongest association with serum 
retinol concentrations in infants. Serum retinol concentrations and weight of infants were 
also associated. 
Discussion 
The present study shows that vitamin A supplementation during pregnancy benefited 
serum retinol concentrations of infants at ~4 months of age. This is consistent with our 
finding that mothers in the weekly vitamin A and iron group maintained their serum 
retinol concentrations near term in contrast to mothers in the weekly iron group where 
levels decreased [18]. Our finding is also in line with the study of Katz et al. [22], showing 
that weekly supplementation with 7000 RE vitamin A of Nepalese women before and 
during pregnancy increased serum retinol concentrations in their infants at 3 months of 
age. 
The difference in serum retinol concentrations of the infants in our study could have 
resulted from differences in the vitamin A stores built up during gestation, from 
differences in retinol concentrations in breast milk, or both [6,23]. It is not yet known to 
what extent vitamin A is transferred via the placenta [23]; however, the vitamin A status of 
pregnant women and that of their newborn infants are associated [7,8]. In addition, in an 
intervention study, Panth et al. [9] showed that vitamin A supplementation of pregnant 
women increased cord levels of vitamin A. A single dose of 60000 or 90000 RE to 
lactating women has been shown to increase their breast milk levels and improved infant 
vitamin A status even up to 6 to 8 months after supplementation [24,25]. Although 
women in our study were supplemented weekly during pregnancy the amount of vitamin 
A given (20 weeks x 4800 RE = 96000 RE) as well as the difference in serum retinol 
concentrations of infants were comparable [24,25]. In addition all infants but 1 were 
breast-fed and not given vitamin A-rich foods (data not shown). Therefore, we can 
assume that they depended on their stores and breast milk intake for vitamin A supply. 
Vitamin A supplementation did not affect infant iron status, which is not surprising 
considering the small increase in haemoglobin and decrease in serum ferritin 
concentrations in their mothers during pregnancy [18]. Nutritional status of infants in the 
weekly iron group was similar to that of infants in the 'daily' group. This is in line with our 
finding that, in terms of improving iron status of mothers during pregnancy, supervised 
weekly iron supplementation performed no better or no worse than the national 
programme [18]. Infant and maternal iron status were not associated except for an 
association of haemoglobin concentrations of mothers ~4 months postpartum and 
infants. The relatively small range of maternal indicators of iron status and amount of iron 
taken during pregnancy, as compared to a placebo-controlled study in Niger in which 
pregnant women were supplemented with 100 mg Fe /d [13], may explain the lack of a 
relationship with infant iron status. 
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Infants are born with low reserves of vitamin A, even if their mothers have an 
adequate vitamin A status [6,26]. Therefore, a cut-off level of 0.35 fimol/L for infants 
after 1 month of age has been proposed [27]. Serum retinol concentrations of our infants 
were low but consistent with values in Bangladeshi, Indonesian and Zambian infants [28-
30], although in the last study only 1% had serum retinol concentrations <0.35 umol/L. 
In our study 3% of infants from mothers supplemented with vitamin A had levels <0.35 
umol/L as compared to >10% in the other 2 groups. It would be useful to compare 
serum retinol concentrations of our infants with those from developed countries, but 
unfortunately we are not aware of any publications reporting such data. The high 
proportion of infants with serum retinol concentrations <0.70 Jlmol/L would indicate this 
population as having a severe public health problem [31], although it should be taken into 
account that these criteria are based on children aged 6-71 months of age. 
Results reported from various studies on the effect of vitamin A on growth of 
children are not consistent [32]. However, vitamin A supplementation has been found to 
improve growth of children in an area with vitamin A deficiency [33] or of children with 
xerophthalmia [34]. The association between weight and serum retinol concentrations 
suggests that vitamin A plays a role in growth, but probably the increase in serum retinol 
concentration was too small to have a significant effect. Supplementation of vitamin A has 
been shown to reduce duration of respiratory tract infection [28]. However, the negative 
association between serum retinol concentrations and respiratory tract infection might 
also be a consequence of infection-induced changes in nutrient transport [35]. 
Values of parameters of iron status we have reported are normal for infants of these 
ages [36]. Serum ferritin concentration as an indicator of iron status has been found to 
decrease with age and to be determined by gender and neonatal weight [37]. Although half 
of the mothers were anaemic or iron deficient during pregnancy [18], it seems that their 
infants had sufficient iron status at least until 4 months of age. We do not know to what 
extent serum ferritin concentrations of our infants were influenced by infection. Signs and 
symptoms of disease, except for skin disease, did not affect serum ferritin concentration 
of infants, but we did not monitor infection, for example, by measuring serum C-reactive 
protein concentrations. However, concentrations of sTfR provide a quantitative measure 
of iron status that is not affected by infection [21]. In general, sTfR concentrations in our 
infants were low, which is indicative of an adequate iron status, and only 4 infants had 
concentrations higher than reported reference values for children of 6 months to 2 years 
(1.48-3.51 mg/L) [21]. The strong inverse correlation of concentrations of serum ferritin 
and sTfR also suggests that the high serum ferritin values were mostly a reflection of high 
stores [38]. 
In conclusion, in a population with marginal vitamin A deficiency, weekly 
supplementation of women during pregnancy with 4800 RE vitamin A in the presence of 
concurrent iron supplementation benefits vitamin A status but not iron status, length or 
weight of their infants. Iron status of infants at ~4 months of age was considered 
sufficient irrespective of supplementation regime. The difference in serum retinol levels 
between infants from vitamin A supplemented pregnant mothers and their counterparts 
were similar as found in studies which provided supplementation to mothers during 
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lactation [24,25]. Therefore, supplementation during pregnancy could be an alternative or 
an addition to supplementation during lactation and has the advantage that it can be 
implemented in the existing iron supplementation programme. However, considering the 
large proportion of infants with serum retinol concentration <0.70 (J,mol/L, we need to 
investigate the relevance of marginal serum retinol concentrations further in infants 
younger than 6 months, and whether it is necessary to increase vitamin A intake during 
infancy. 
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Randomised double-blind trial of the effect of 
vitamin A supplementation of Indonesian pregnant 
women on morbidity and growth of their infants 
during the first year of life 
Marjanka K. Schmidt, Siti Muslimatun, Werner Schultink, Clive E. West and Joseph 
G.A.J. Hautvast 
ABSTRACT 
Objective: To investigate whether supplementation with vitamin A together with iron of 
Indonesian pregnant women decreases morbidity and improves growth of their infants 
during the first year of life. 
Design: Women from a rural area in West Java, Indonesia, had been randomly assigned 
on an individual basis to double blind supplementation once weekly from ~18 weeks of 
pregnancy until delivery. Supplementation comprised 120 mg iron and 500 u.g folic acid 
with or without 4800 RE vitamin A. Their newborn infants were followed up during the 
first year of life: weight, length, morbidity and food intake were assessed monthly. 
Results: Infants whose mothers had taken vitamin A supplements during pregnancy had 
similar weight, length, weight gain and growth as their counterparts during the follow-up 
period. The proportions of infants with reported symptoms of morbidity were similar in 
the vitamin A plus iron group and the iron group. In addition immunisation coverage and 
feeding mode did not differ between the groups. All infants were breast-fed but exclusive 
breast-feeding rapidly declined at 4 months of age. Infants with serum retinol 
concentrations >0.70 umol/L increased their weight and length more during the first 6 
months of life and had higher weight-for-age z-scores during the first year of life than 
infants with serum retinol concentrations <0.70 umol/L. Serum retinol concentrations 
were not associated with morbidity. 
Conclusion: In this study, vitamin A supplementation in conjunction with iron 
supplementation of pregnant women did not improve growth or reduce morbidity of their 
infants during the first year of life. 
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Vitamin A is one of the essential nutrients for health and development of infants [1], 
which is shown by the reduction in mortality and morbidity by vitamin A supplementation 
of infants aged 6 months and older in populations with vitamin A deficiency [2,3]. 
However the impact of vitamin A supplementation on mortality and morbidity of infants 
younger than 6 months is less conclusive [4-6]. Vitamin A supplementation during 
lactation has been shown to improve vitamin A status and reduce morbidity of infants 
through its effect on breast milk [7-9]. 
As reviewed before [10] the effect of vitamin A supplementation on growth is 
inconsistent. However vitamin A supplementation has been shown to improve growth of 
children in populations with vitamin A deficiency or xerophthalmia [11-14], suggesting 
that vitamin A supplementation may be beneficial for growth in populations in which 
vitamin A is a limiting factor. 
In Indonesia, a large proportion of infants have micronutrient deficiencies and are 
underweight or stunted [15,16]. Inadequate maternal nutrition during pregnancy is thought 
to be one of the contributors to this [17-19]. Vitamin A supplementation of women 
before and during pregnancy has been shown to reduce maternal night blindness and 
mortality [20,21] and improve serum retinol levels in infants [22,23] (Chapter 2). However 
it did not reduce foetal loss or early infant mortality [22] and other outcomes of infants 
have not been reported so far. 
Indonesia is one of the many countries that use iron supplementation for controlling 
maternal anaemia during pregnancy [24]. Supervised weekly iron supplementation has 
been shown to perform similar to the ongoing governmental iron supplementation 
programme in preventing iron deficiency anaemia [25]. In this study, we investigated 
whether vitamin A supplementation in concurrence of iron supplementation to 
Indonesian pregnant women decreases morbidity and improves growth of their infants 
during the first year of life. 
Subjects and methods 
Study design 
The study was carried out in infants from 5 rural villages in Leuwiliang subdistrict, Bogor 
district, West Java, Indonesia. At —17 weeks of pregnancy, their mothers had been 
randomly assigned on an individual basis to a double blind, supervised supplementation 
once weekly from enrolment until delivery. Supplementation comprised 120 mg iron as 
ferrous sulphate and 500 ug folic acid or the same amounts of iron and folic acid plus 
4800 RE vitamin A. Details of the study design and the effect of supplementation on 
maternal biochemical status near term and infant biochemical status at ~4 months of age 
have been published elsewhere [23,25] (Chapter 2). After birth, infants were followed up 
during the first year of life. Growth, morbidity and nutrition were assessed monthly, while 
biochemical status was assessed at ~4 months of age. The study had been explained to the 
women at enrolment and only women who gave written informed consent were enrolled. 
The research was approved by the Ministry of Health Indonesia and the Ethical 
Committees of the Medical Faculty at the University of Indonesia and Wageningen 
University. 
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Monthly assessment 
Weight and length of infants were measured and mothers interviewed for morbidity and 
food intake of their infants during their monthly visit to their neighbourhood health post 
(Posyandu). In principal visits for each health post were planned on the same date of each 
month. However, in practice visits were made within 1 week before or after the planned 
date. It was attempted to reach individual mothers who were not able to attend during a 
visit at their home. 
Anthropometry Two pairs of trained field assistants measured weight and length of 
infants. Weight was measured to the nearest 50 g by using a baby weighing scale (Misaki, 
Japan) which was tared each time before use. Calibration with a standard weight (5 kg) at 
regular intervals showed that all scales were stable and precise. Recumbent length was 
measured to the nearest 0.1 cm by using a wooden length board (SEAMEO TROPMED). 
Infants were measured with light clothing. Neonatal weight and length of infants had been 
measured by 2 of the authors (MKS and SM) during a postnatal home visit [23] (Chapter 
2). All field assistants had received training and were supervised every month by the 2 
authors mentioned above. At each supervision the supervisors also independently 
measured length and weight in a random sub-sample of ~ 5 % of the infants (total n=163). 
The mean technical error, expressed as a standard deviation (SD=VXd2/2n, d=difference 
between paired measurements, n=number of infants) was 44 g and 0.70 cm. In addition 
SD of pooled duplicate measurements in a random sample by the field assistants 
(recorded n=25) was 35 g and 0.46 cm. The reliability coefficients of the anthropometric 
measurements were high, 0.967 and 0.997 for length and weight respectively [26]. 
Morbidity At the time of the anthropometric assessment the same field assistants 
interviewed the caretaker, in all but 2 cases the mother, of the infant about symptoms of 
morbidity in the 14 days preceding the visit. More specifically, mothers were asked to 
recall: diarrhoea, defined as >3 stools that were more liquid than usual in one day; fever, 
mother's evaluation of infant's body temperature above normal (hot to the touch; 'panas'); 
running nose ('pilek'), nasal discharge; cough, persistent coughing; difficulty breathing, 
breathing with severe noise or wheezing or difficulty inhaling; ear discharge, fluid or pus 
draining from at least one ear; or vomiting. Questions were asked in Bahasa Indonesia or 
in the local language (Sundanese) if the mother did not understand the term. First the 
interviewer asked the mother for any symptoms and then asked her specifically for each 
category and for how many days the infant suffered from that specific symptom. Episodes 
were defined as a period of sickness separated by at least 3 days. Morbidity incidence rates 
were determined as total number of episodes divided by the number of days at risk. Days 
at risk were defined as the number of days on which morbidity was assessed (number of 
interviews x 14 days) minus the number of days not at risk, i.e. the total of days on which 
a symptom was reported plus 3 days for each separate episode. 
In addition mothers were asked whether the infant had received immunisation since 
the last interview. Data on immunisation were crosschecked against the Posyandu record 
of growth and immunisation. If inconsistencies were found data from the record were 
used. Mortality of infants was recorded at a home visit after death had been reported. 
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Breast-feeding and food intake Together with the morbidity interview the mother was 
asked whether the infant was still breast-fed and whether the infant received any other 
liquid or food in the 14 days preceding the visit. Data on breast-feeding and food intake 
had also been collected at the postnatal home visit. The type of liquid or food was 
recorded using a pre-coded questionnaire. Infants were categorised as exclusively breast-
fed, predominandy breast-fed (i.e. receiving breast milk plus water, tea, coffee or fruit 
juices, but no artificial milk), complementary fed, or non breast-fed [27]. 
Biochemical measures 
At ~4 months of age, non-fasting venous blood samples (~2 mL) were taken from infants 
and collected in a tube without anticoagulant between 09.00 and 12.00 h. It was not 
possible to obtain blood from all subjects due to maternal refusal and in some cases the 
amount of blood obtained was insufficient for all analyses. Haemoglobin was determined 
using the cyanmethemoglobin method (Test 3317; Merck, Darmstadt, Germany) at the 
Nutrition Research and Development Center laboratory, Bogor. For serum ferritin, 
soluble transferrin receptor and retinol analyses, blood was allowed to clot before it was 
placed in a cool box with cooling elements for transport to the laboratory in Bogor. Blood 
samples were centrifuged at 3000 g for 10 minutes at room temperature and serum was 
distributed among three vials. Serum was kept at -20°C for 1 month and subsequendy at 
-79°C. All analyses were carried out within 1 year of blood collection and have been 
described earlier [23] (Chapter 2). 
Data analysis 
Infants whose mothers had been supplemented during pregnancy with vitamin A plus 
iron (n=107) or iron alone (n=105) and who attended at least once the assessment at the 
health post were included for analysis (Figure 3.1). Infant's weights and lengths were 
converted into z-scores using the N C H S / W H O reference data incorporated in the Epi-
Info software (Epi Info2000 version 1.0.5. CDC, Adanta). N C H S / W H O reference data 
were also used to construct a reference curve weighed for the number of boys and girls in 
the study population. For analysis, follow-up data of infants were grouped into monthly 
age groups of 0 (0-0.99 months) to 12 (12-12.99 months). For additional analysis and 
presentation, morbidity and breast-feeding data were pooled into 4 age categories 
reflecting the different periods of mode of feeding and vulnerability to morbidity: 0-3, 4-6, 
7-9 and 10-12 months. Differences in age, anthropometric and biochemical variables 
between groups were evaluated by independent Atest. Differences in proportion were 
evaluated by %2-test. Data of morbidity were not normally distributed, therefore 
differences between groups were evaluated using non-parametric tests. For the analysis of 
growth and morbidity in relationship with serum retinol concentrations data of all infants 
were pooled and evaluated by /-test, ANOVA and multiple regression analysis as 
appropriate. The SPSS software package (Windows version 7.5.2. SPSS Inc., Chicago, IL) 
was used for all statistical analyses and a P value of <0.05 was considered as significant. 
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9 women stopped 
supplementation 
3 stillbirth 
1 infant died after birth 
2 moved after birth 
107 infants 
followed up 
9 women stopped 
supplementation 
3 stillbirth (including 1 twin) 
1 infant died after birth 





96 infants followed up 
until 1 year of age 
4 moved 
4 died 
97 infants followed up 
until 1 year of age 
Figure 3.1 Study profile. 
Results 
Infants were followed up at least until 1 year of age from May 1998 until November 1999. 
During this period 11 infants in the vitamin A plus iron group and 8 infants in the iron 
group were lost to follow-up as a result of emigration from the research area or death 
(Figure 3.1). Infants were measured monthly but, because visits were not always on the 
same date, and due to temporary absence, refusal of the mother or sickness of the infant, 
some of the infants were not measured. In total 2330 anthropometric assessments, 
including 219 measurements at the postnatal visit, and 2188 morbidity interviews were 
made during the first year of follow-up. 
The coverage of anthropometric measurements of infants at each monthly visit was 
>80%. Coverage or gender of infants did not differ between the vitamin A plus iron 
group and iron group at any monthly visit. We obtained 11-14 anthropometry 
measurements from 81.6% of the infants, 8-10 from 11.8% and 2-7 from 6.6%. The mean 
(SE) number of measurements of 11.5 (0.3) and period of follow-up of 11.3 (0.3) months 
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in the vitamin A plus iron group were similar to those in the iron group, 11.9 (0.2) and 
11.6 (0.2) months respectively. 
Length and weight of infants who were supplemented with vitamin A during 
gestation did not differ from their counterparts at any age during the first year of life 
(Figure 3.2). During the 1 year follow-up the mean increase in length and weight gain of 
infants in the vitamin A plus iron group, 20.8 (0.5) cm (SD) and 4.78 (0.12) kg 
respectively, were similar to those in the iron group, 21.3 (0.4) cm and 4.83 (0.11) kg 
respectively. Selection of infants who had been followed up for >10 months or excluding 
infants who dropped out because of death or migration did not alter these results. Weight 
and length of all infants started to deviate below the N S C H / W H O reference population 
at 5 months of age (Figure 3.2). At 12 months of age 23 and 3 3 % of the infants had z-
scores <-2 for height-for-age and weight-for-age respectively. 
The proportion of infants with reported health complaints were similar in both 
groups (Table 3.1). Except that there were small inconsistent differences in reporting of 
cough between groups at 0-6 months of age (Table 3.1). The results were consistent if 
expressed and analysed as number of days, number of episodes or number of days per 
episode or incidence ratio (Table 3.2). Symptoms of morbidity were not related to gender 
of the infant. 
Immunisation coverage was similar in both groups, 90.5% of the infants had at least 
received 1 vaccination of BCG (bacille Calmette-Guerin), oral polio and D T P (diphtheria, 
pertussis and tetanus) during the first year of life. Only 6.7% of the infants had already 
fully complied with the immunisation schedule, i.e. 1 BCG, 3 DTP, 4 polio, 1 measles and 
3 hepatitis, at 1 year of age. During the study, 9 infants in the vitamin A plus iron group 
and 9 infants in the iron group received a vitamin A supplement from the midwives. This 
occurred at a mean age of 10.4 (3.9) months. 
At the time of the postnatal visit, 208 of the 219 mothers were already breast-feeding 
their infants but 26 of these discarded some of the colostrum. A large proportion (84%) 
of mothers also gave some form of prelacteal feeding to their infants: formula milk, 7%; 
water, 14%; honey, 71%; banana, 14%; or other food or drinks, 34%. All but 1 infant 
were breast-fed at least until 6 months of age. The proportion of infants that were 
exclusively breast-fed, predominantly breast-fed, complementary fed or non breast-fed did 
not differ between the groups (Table 3.3). If we consider an infant no longer to be 
breast-fed exclusively because of having received prelacteal feeding, the proportion of 
infants that were exclusively breast-fed was small in both groups (Table 3.3). In both 
groups exclusive breast-feeding, whether or not taking into account prelacteal feeding, 
declined rapidly from 4 months of age while complementary feeding increased (Table 
3.3). 
Boys increased their length more and gained more weight than girls during the first 
year of life (Table 3.4). During the first 6 months of life, infants with serum retinol 
concentrations >0.70 |J.mol/L increased their weight and length more than those with 
serum retinol concentrations <0.70 |0,mol/L (Table 3.4). These differences remained 
significant if correcting for neonatal weight or length, serum ferritin and haemoglobin 
concentrations, supplementation group and gender. In addition infants with serum retinol 
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concentrations >0.70 (Imol/L had higher z-scores for weight-for-age during the first year 
of life (Figure 3.3); similar trends were seen for height-for-age and weight-for-height z-
scores. Infants with serum retinol concentrations >0.70 |J.mol/L had similar prevalences 
of morbidity and did not differ with respect to type of feeding compared to infants with 
serum retinol concentrations <0.70 H-mol/L (data not shown). 
5 6 7 
Age, months 
9 10 11 12 
5 6 7 
Age, months 
9 10 11 12 
Figure 3.2 Mean (SE) length and weight of infants from 0 to 12 months in the vitamin A 
plus iron group, iron group and reference values based on the NCHS standards. 
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Figure 3.3 Mean (SE) weight-for-age Z-scores at 0 to 12 months of age of infants with 
serum retinol concentrations >0.70 flmol/L and <0.70 |j,mol/L; differences evaluated by 
t-test, at 4 months: P =0.066, at 6 months: P =0.045, at 7 months: P =0.052. 
Table 3.1 Proportion of infants in the vitamin A plus iron group and iron group suffering 































































































'Difference between the vitamin A plus iron group and iron group by %2-test, P =0.040, 
tP =0.022, *P =0.026. 
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Table 3.2 Morbidity incidence (episodes per 100 infant days) of infants in the vitamin A 
plus iron group and iron group during the follow-up period 
Number of episodes Incidence risk ratio 



























Table 3.3 Proportion of different feeding modes of infants in the vitamin A plus iron 
group and iron group by age category 
Vitamin A + iron Iron 
Age category (months) 0-3 4-6 7-9 10-12 0-3 4-6 7-9 10-12 
% 
Taking into account prelacteal feeding 
Exclusively breastfeedingt 9.1 0.4 
Predominandy breastfeeding} 49.1 13.8 4.4 
Not taking into account prelacteal feeding 
Exclusively breastfeedingt 54.2 8.2 
Predominandy breastfeedingt 4.0 6.0 
Complementary feedingt 41.8 85.4 
Non breastfeeding* 0 0.4 
'Different between groups by %2-test, P =0.034; tTrends in vitamin A plus iron group and 
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Table 3.4 Weight gain and length increase by gender and serum retinol concentrations of 
infants during the first year of life* 
Weight gain (kg) Length increase (cm) 
0-12 months 0-6 months 0-12 months 0-6 months 
Gendert 
Boys 5.27 ± 0.09 (71)i 4.28 ± 0.09 (78)2 22.7 ± 0.3 (71)3 16.5 + 0.2 (78)4 
Girls 4.84 ± 0.08 (92) 3.94 ±0.07 (101) 21.9 ±0.2 (91) 15.8 ±0.2 (100) 
Serum retinol 
concentrationstt 
<0.70flmol/L 4.94 ±0.08 (80) 3.99 ± 0.07 (87)5 22.1 ±0 .3 (79) 15.7 ± 0.2 (86)6 
>0.70|Xmol/L 5.20 ± 0.23 (21) 4.34 ±0.19 (23) 22.8 ±0.5 (21) 16.6 ±0 .4 (23) 
*Mean ± SE (n); tSignificant difference between gender by /-test or ttserum retinol 
concentrations by ANOVA corrected for gender, W =0.001, 2P =0.002, 3P =0.023, 
4P =0.017,5P =0.036,6P =0.048. 
Discussion 
In this study we demonstrated that weekly supplementation of pregnant women in 
Indonesia with vitamin A did not improve growth or reduce morbidity in their infants 
during the first year of life. This is in line with the findings of Katz et al. [22], who found 
that foetal loss and early infant mortality were not reduced when Nepalese women were 
supplemented weekly with vitamin A during pregnancy. However vitamin A 
supplementation was beneficial in terms of reducing mortality in pregnant women [20]. In 
addition vitamin A supplementation has been shown to reduce morbidity and mortality in 
children under 5 years old [2,3]. However it should be noted that this reduction in 
morbidity and mortality is only seen in children above the age of 6 months. Earlier we 
reported a significant but small difference in serum retinol concentrations of infants of the 
vitamin A plus iron group and iron group [23] (Chapter 2). However the amount of 
vitamin A given may have been too small to provoke an additional impact on infant 
growth or morbidity. On the other hand even infants given a large dose of vitamin A only 
had a small increase in serum retinol concentration and similar morbidity compared to 
infants given a placebo [28]. In addition a large trial in which infants were supplemented 4 
times with 25000 IU vitamin A and their mothers once with 200000 IU did not show any 
effect on anthropometric status or morbidity of infants, although vitamin A status at 6 
months of age improved [5]. 
In our study, we supplemented pregnant women with 4800 RE vitamin A each week. 
This amount is in line with W H O guidelines [29], which allow a maximum weekly dose of 
7500 RE, and does not exceed the Indonesian RDA of 700 RE per day [30]. Although the 
amount of vitamin A given may have been too small to have an impact on infant growth 
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or morbidity, intake during pregnancy cannot be increased because of the teratogenic 
effects of vitamin A [29]. 
Iron supplementation of both groups could partly explain the lack of effect of vitamin 
A supplementation on growth and morbidity [31]. In a study in Tanzanian school 
children, vitamin A plus iron supplementation also did not have an impact an growth 
compared to iron supplementation [13]. Increase in iron stores of the infant through 
maternal iron supplementation during pregnancy may also have improved growth of our 
infants [32,33]. 
The relationship of xerophthalmia, which is indicative of severe vitamin A deficiency, 
with stunting, wasting and smaller increases in length and weight than non-xeropthalmic 
counterparts has been established [34,35]. We have shown that infants with serum retinol 
concentrations >0.70 umol/L increased their weight and length more and had higher 
weight-for-age z-scores until 1 year of age as compared to their counterparts. More of 
these infants were in the vitamin A plus iron group (26%) than in the iron group (16%); 
however, this difference was not significant (P =0.241). Infants started growth faltering 
and becoming underweight at 4-6 months of age as is typically seen in Southeast Asian 
and populations of other developing countries, and has been associated with factors such 
as nutrition, morbidity, prenatal nutrition, birth weight and parental height [36-39]. The 
use of the N C H S / W H O reference has been criticised because it is not based on breast-
fed infants, but if we compared our infants to the W H O 12 months-breast-fed pooled 
data the same trends were visible, although the deterioration was smaller (data not shown) 
[40]. 
The use of parental report as a method to establish morbidity has been suggested to 
be one of the reasons for the inconsistencies found in the effect of vitamin A 
supplementation on morbidity in community-based studies [41]. However mothers have 
been found to report sickness of their children quite well [42] and as education levels and 
other characteristics of mothers in both groups were comparable (data not shown), we do 
not expect that over- or under-reporting would be different between the groups. 
Morbidity prevalence could have been underestimated because we interviewed mothers 
only once a month about the past 14 days [43]. However incidence of cough was 
comparable to that reported for infants from developing countries [5]. Also other studies 
in which infants were supplemented with vitamin A did not show an effect on diarrhoea 
or respiratory diseases [44,45], or only an effect on duration of acute respiratory infections 
[46]. 
The type of feeding during the first year of life and immunisation coverage were 
comparable between the groups, thus these could not have accounted for the lack of 
difference in growth and morbidity of infants. We conducted 2-weeks recalls using a pre-
coded questionnaire, because a trial of 24-hour recalls in mothers showed that this would 
be a more reliable measure of intake of foods other than breast milk. Although our 
method had the disadvantage of relying more on the mothers memory, obtaining dietary 
information for the 24 hours before each visit may overestimate exclusive breast-feeding 
because some infants may receive fluids or foods on less than daily basis [47]. 
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Until 5 months of age infants in this population grew well, but thereafter growth 
faltering occurred, therefore further research is necessary regarding improvement of 
growth of infants after 4-6 months of age. The association between serum retinol 
concentrations and growth indicates that vitamin A plays a role in growth [34]. However 
our study showed that in populations that are marginal vitamin A deficient [25] vitamin A 
supplementation in conjunction with iron supplementation during pregnancy on 
community level has no impact on growth or morbidity of infants. 
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Patterns and determinants of growth faltering and 
nutritional status in Indonesian infants 
Marjanka K. Schmidt, Siti Muslimatun, Clive E. West, Werner Schultink, Rainer Gross 
and Joseph G.A.J. Hautvast 
ABSTRACT One of the health problems in Indonesia is the high prevalence of stunting 
in infants. In order to design appropriate interventions, growth patterns and the 
contribution of prenatal and postnatal factors to growth faltering and nutritional status of 
Indonesian infants were investigated. Newborn infants, from women recruited at —18 
weeks of pregnancy from 9 rural villages in West Java, Indonesia, were followed up to 12 
to 15 months of age. Growth, morbidity, breast-feeding and food intake were assessed 
monthly. At enrolment, mothers were interviewed and anthropometry assessed. At birth, 
weight and length of infants and feeding practices were assessed. Determinants of growth 
and nutritional status were evaluated using multiple linear regression. Infants were born 
with reasonable weight and length while growth started to falter at 6-7 months of age. 
Stunting was highly prevalent at 12 months of age. Almost all infants were breast-fed and 
received complementary feeding. Morbidity was negatively and food intake positively 
associated with growth and nutritional status of infants. The most important determinants 
of increases in weight and length and nutritional status were neonatal weight and length, 
reflecting prenatal factors. Maternal factors and postnatal factors were of equal strength in 
predicting growth and nutritional status of infants. In order to have the highest chance of 
achieving a measurable effect on infant growth, interventions should be aimed at both 
improving infant nutritional status and ensuring that women enter pregnancy with good 
nutritional status. 
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About one third of Indonesian infants and children are underweight or stunted [1,2]. 
Stunting indicates a public health problem because of its association with an increased risk 
of morbidity and mortality, delayed motor and mental development, and reduced physical 
capacity [2,3]. Most growth faltering, resulting in underweight and stunting, occurs from 
birth until about 2 years of age and may already start during the gestation period [3]. 
During infancy and childhood, inadequate intakes of nutrients and frequent or prolonged 
episodes of infections may exacerbate the effects of foetal growth retardation [2,4]. 
Infection can affect nutrition through anorexia, impaired nutrient absorption, 
micronutrient losses in urine, increased metabolism or impaired transport to target tissues 
[5,6]. However, the severity of the effect of morbidity on growth depends on the 
pathogens and population involved [5,7]. 
Breast-feeding has been found to decrease the risk of morbidity and mortality in 
infants in developing countries [8,9] and morbidity in developed countries [10]. In 
addition growth of breast-fed infants differs from those who are formula-fed [11]. 
However the effects of duration of breast-feeding, early introduction of food or liquids, 
and complementary feeding on growth differ among populations [12-18]. In addition, to 
nutrition and morbidity, factors such as maternal nutrition during pregnancy and parental 
anthropometric variables could account for differences in growth patterns during infancy 
and childhood [3,4,19]. 
Stunting is an irreversible process and therefore it is important to take preventive 
measures during gestation or early infancy [20]. However, determinants of stunting 
depend on the ecological setting [21] and, in order to improve intervention strategies, it is 
important to know the relative contribution of prenatal versus postnatal nutrition to 
growth faltering during infancy [22]. Up to now, little information is available from 
Indonesia on growth of infants. We have shown that infant iron and vitamin A status are 
associated with their nutritional status and growth [23,24] (Chapter 2 & 3), however, other 
determinants have not yet been analysed and published. Therefore, the aim of this article 
is to present growth patterns and the influence of prenatal and postnatal factors on 
growth faltering and nutritional status of Indonesian infants. 
Methodology 
Study design 
Pregnant women from 9 rural villages in Leuwiliang subdistrict, Bogor district, West Java, 
Indonesia were enrolled in 6 rounds from November 1997 until May 1998 and their 
infants were born from February until November 1998. After birth all eligible infants were 
followed up monthly up to at least 12 months of age. Thereafter infants, whose mothers 
were still willing to participate, continued to be measured into childhood until the end of 
the study period (November 1999). Growth, morbidity, breast-feeding and food intake 
were assessed monthly. In addition, mothers were interviewed at enrolment for socio-
economic background and pregnancy history, at delivery for infant food intake and other 
variables and at 13 months after delivery about the use of contraceptives and pregnancy 
status. Selected anthropometric measurements of women [25] were assessed at enrolment, 
near term and ~4 months postpartum. The data presented in this paper were collected in 
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an intervention trial investigating the effect of vitamin A and iron supplementation during 
gestation on infant growth. The results of the intervention and details of the study design 
have been published earlier [23-26] (Chapter 2 & 3). Explanation of the study had been 
given to the women at enrolment and all women who participated gave written informed 
consent. The Ministry of Health Indonesia and the Ethical Committees of the Medical 
Faculty at the University of Indonesia and Wageningen University approved the research 
proposal. 
Study population 
Of 366 women recruited at ~18 weeks of pregnancy, 318 infants were eligible for follow-
up after birth. Drop-out of subjects had occurred because of withdrawal from 
supplementation (n=18), moving outside the research area (n=15), stillbirth (n=13) or 
neonatal death (n=2) [23,25] (Chapter 2). During the follow-up period from birth to 12 
months, 16 infants moved outside the research area and 12 infants died. Neonatal weight 
or length and gender ratio did not differ between infants that dropped out and infants that 
were followed up to 12 months (n=290). All 318 infants experienced at least 
1 anthropometric assessment. Infants who were measured 1-9 (n=46), 10-13 (n=100) or 
14-19 (n=172) times did not differ with respect to neonatal weight or length, weight gain 
or length increase during the first 6 months of life and gender ratio. The average number 
of measurements was 13.2 ± 3.6. 
Assessment of infants 
Weight and length of infants were measured and mothers interviewed for morbidity and 
food intake of their infants during their monthly visit to their neighbourhood health post 
(Posyandu). In principle, visits for each health post were planned on the same date of each 
month. However, in practice visits were made within 1 week before or after the planned 
date. It was attempted to reach individual mothers who were not able to attend during a 
visit at their home. 
Anthropometry Two pairs of trained field assistants measured weight and length of 
infants using standardised methods [27]. Weight was measured to the nearest 50 g by 
using a baby weighing scale (Misaki, Japan), which was tared each time before use. 
Calibration with a standard weight (5 kg) at regular intervals showed that all scales were 
stable and precise. Recumbent length was measured to the nearest 0.1 cm by using a 
wooden length board [28]. Infants were measured with light clothing. Neonatal weight 
and length had been measured by 2 of the authors (MKS and SM) during a postnatal 
home visit [23] (Chapter 2). All field assistants had received training and were supervised 
every month by the 2 authors mentioned above. Independent measurements performed in 
a random sub-sample of —5% of the infants revealed a high reliability of the 
measurements [24] (Chapter 3). 
Morbidity At the time of the anthropometric assessment the same field assistants 
interviewed the caretaker, in all but 2 cases the mother, of the infant about symptoms of 
morbidity in the 14 days preceding the visit. More specifically, mothers were asked to 
recall: diarrhoea, defined as >3 stools in 1 day that were more liquid than usual; fever, 
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mother's evaluation of infant's body temperature above normal (hot to the touch; 'panas^; 
running nose ('pilek'), nasal discharge; cough, persistent coughing; difficulty breathing, 
breathing with severe noise or whee2ing or difficulty inhaling; ear discharge, fluid or pus 
draining from at least 1 ear; vomiting. Questions were asked in Bahasa Indonesia or in the 
local language (Sundanese) if the mother did not understand the term. First the 
interviewer asked the mother for any symptoms and then asked her specifically for each 
category and for how many days the infant suffered from that specific symptom. Episodes 
were defined as a period of sickness separated by at least 3 days. Mortality of infants was 
recorded at a home visit after death had been reported. 
Breast-feeding and food intake Together with the morbidity interview the mother was 
asked whether the infant was still breast-fed and whether the infant received any other 
liquid or food in the 14 days preceding the visit. Data on breast-feeding and food intake, 
including food given to the infant before or at the time of starting the breast-feeding i.e. 
prelacteal feeding, had also been collected at the postnatal home visit. The type of liquid 
or food was recorded using a pre-coded questionnaire. For breast-feeding status, infants 
were categorised as exclusively breast-fed, predominandy breast-fed (i.e. receiving breast 
milk plus water, tea, coffee or fruit juices, but no artificial milk), complementary fed, or 
non breast-fed [29]. Here, we refer to infants breast-fed exclusively as those infants who 
were exclusively breast-fed regardless of whether they received prelacteal feeding. For data 
analysis, infant food intake was categorised as follows, animal products: meat (beef or 
chicken), liver, egg, fish; biscuits: biscuit, bread, noodles, porridge (bean or wheat-flour); 
fruit: banana and other; rice, rice, rice porridge, rice steamed in banana leaves ('lontong'); 
tempeh: tempeh or tofu ('tahu'); vegetables: carrot, dark green leafy vegetables, cabbages, 
(french) beans, potato and other; snacks: fried (sweet) potato or cassava (in small quantities 
not with the meal), bakso (flour and meat balls), cookies (other than biscuit), chips, 
krupuk, agar-agar, candies; milk: milk, infant formula, fortified infant food; liquids: water, 
tea and/or coffee with or without sugar, honey, fruit or vegetable juice. 
Data analysis 
Data of 318 infants eligible for follow-up were pooled for analysis irrespective of the 
treatment that their mothers had received during pregnancy. Growth, morbidity, iron 
status and feeding mode of infants did not differ from 0 to 12 months of age among the 3 
treatment groups, although serum retinol concentrations were improved by vitamin A plus 
iron supplementation [23,24] (Chapter 2 & 3). In addition no differences in growth were 
found among groups up to 18 months of age (unpublished data). Therefore, we consider 
that pooling of data of infants for analysis of determinants of growth faltering is justified. 
Weight and length were converted into z-scores using the N C H S / W H O reference data 
incorporated in the Epi-Info software (Epi Info2000 version 1.0.5. CDC, Atlanta). 
Stunting was defined as a height-for-age z-score of <-2, underweight as weight-for-age z-
score <-2 and wasting as weight-for-height z-score <-2. For analysis, follow-up data of 
infants were grouped into monthly age groups of 0 (0 until 0.99 months, neonatal) to 18 
(18 until 18.99 months). However, we considered that only up to 15 months of age the 
number of follow-up (anthropometric) data of infants that was available for analysis was 
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still reasonable (n=128), therefore, descriptive data are presented until that age. For 
further analysis, we present the follow-up data up to 12 months to reduce the risk of 
selection bias and to increase power by having more infants in the analysis. 
For the analysis of association of symptoms of morbidity or food groups with growth, 
nutritional status or feeding practices and for multiple linear regression, morbidity 
symptoms and food intake were converted into a ratio correcting for compliance to the 
assessments as follows: the total number of episodes of a symptom or the total number of 
times a certain food group was reported to be consumed by the infant was divided by the 
total number of assessments this infant had during the follow-up period. 
Comparisons of continuous, normally distributed data between groups were done 
using /-test or ANOVA if correction for other variables was necessary. Comparisons of 
continuous, non-normally distributed data and categorical data between groups were done 
using Mann Whitney U-test and %2-test respectively. Associations of normally and non-
normally distributed data were evaluated using Pearson's correlation and Spearman rank 
correlation, respectively. For correction of gender in the association between growth and 
morbidity or food intake partial correlation was applied. Determinants of growth and 
nutritional status of infants were evaluated using backward multiple linear regression 
(threshold 0.1). Variables included in all models are those presented in Table 4.1 and were 
entered as dichotomous or continuous variables. However, mid-upper arm circumference 
was not included in any model because it was highly correlated with maternal weight 
(r >0.8). Occupation of father was entered as dichotomous (0=daily worker, l=monthly 
worker or trader) or as 2 dummy variables, but with neither method became significant in 
the model. Also the variables: prelacteal feeding (0,1), colostrum intake (0,1) and number 
of months the infant was exclusively breast-fed (not taking into account prelacteal 
feeding) were included in all models. When neonatal weight and length were both 
included in all models, neonatal weight was found to be a significant predictor in the 
models for weight gain and weight-for-age z-scores, neonatal length in the models for 
length increase and height-for-age z-scores, and both variables in the model for weight-
for-height z-scores. Because neonatal weight and length were highly correlated (r >0.8), 
models were rerun only including the significant variable (neonatal weight or length, or 
both in the case of weight-for-length). In order to limit the number of variables and to 
avoid collinearity, we selected 1 variable for morbidity symptoms and 1 for food groups to 
be included in the models. The selection was based on a comparison of correlation 
coefficients of each morbidity or food variable with the dependent variable. Fever was 
most associated with growth and nutritional status of infants and was therefore included 
in all models. Of the food groups, fruit was most associated with weight gain, weight-for-
age and height-for-age z-scores, biscuits with length increase and snacks with weight-for-
height z-scores, thus these were included in the respective models. Statistical analysis was 
carried out with the SPSS software package (Windows version 7.5.2. SPSS Inc., Chicago, 
IL). 
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Results 
General characteristics of the study population are shown in Table 4.1. The number of 
boys and girls was not significantly different. Twenty-seven percent of the infants were 
first-borns. Among multiparous mothers, the average period between the present and the 
previous delivery was 44 months, 66 mothers had delivered <24 months and 166 >24 
months ago. At 13 months after delivery 4 mothers of the 281 interviewed reported to be 
pregnant again. 
Table 4.1 General characteristics of subjects followed up1 
Boy / girl (n) 151 / 167 
Birth order 1.5 ±1 .3 
Gestational age, weeks 37.8 ± 2.6 
Maternal age at enrolment,years 24.3 ±4 .6 
Maternal height at enrolment, cm 149.1 ± 4.9 
Maternal weight at enrolment, kg 48.9 ± 6.6 
Maternal MUAC at enrolment, cm 24.6 ± 2.4 
Maternal education (%) 
Elementary school 74.8 
Higher education 25.2 
Occupation of father (%) 
Daily worker (labourer, farmer, driver) 46.5 
Monthly worker (government or private employee, retired) 34.0 
Trader 19.5 
Housing (%) 
Good housing (brick wall, tile roof and cemented floor) 67 
Poorer housing (wall, roof and/or floor made of materials 33 
with less quality) 
'Data are presented as mean ± SD unless stated otherwise. 
Growth and nutritional status of infants Most of the increase in length and weight of infants 
occurred during the first 6 months (Table 4.2). At the neonatal assessment only 7% of 
the infants were stunted, 5% were underweight and none were wasted. This situation was 
similar at 6 months of age. However at 12 months of age, 24% was stunted, 32% 
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underweight and 4% wasted while at 15 months of age these proportions had increased to 
32%, 40% and 6%, respectively. Weight-for-age and height-for-age z-scores started to 
decrease significantly (P <0.05) from 3-4 months of age and weight-for-height z-scores 
from 4-5 months of age (Figure 4.1). However if compared with neonatal nutritional 
status, growth started to falter around 6-7 months of age as shown by the lower z-scores. 
Wasting was the least prevalent: mean weight-for-height z-scores were higher (P <0.0001) 
than weight-for-age and height-for-age z-scores from 0 to 15 months of age (Figure 4.1). 
Stunting was more prevalent than underweight up to 7 months of age as shown by the 
lower (P <0.01) height-for-age z-scores than weight-for-age z-scores, while the situation 
was the reverse (P <0.01) from 9 to 15 months of age. Boys had higher weight and length 
than girls from 0 to 15 months (Figure 4.2). This difference was mainly due to the higher 
birth weight and length of boys, and greater increases in weight [0.39 (0.20-0.57) kg, mean 
(95%CI), P <0.0001)] and length [0.7 (0.2-1.2) cm, P <0.01)] during the first 6 months of 
life. Height-for-age, weight-for-age and weight-for-height z-scores from 0 to 15 months 
did not differ significantly between boys and girls. Compared with the 12-months breast-
fed pooled data set of W H O [11], length and weight of boys and girls started to falter 
from the reference curve around 6-7 months of age. At 12 months of age, mean weight-
for-age and height-for-age z-scores were —1.25 and —1.17 for boys and —1.12 and —1.13 
for girls, respectively. 
Table 4.2 Weight, length and growth of Indonesian young infants from birth to 15 
months of age1 
Age 
<72 hours (birth) 





0 - 6 
6 - 1 2 












3.2 ± 0.5 
7.3 ± 0.9 
8.2 ± 0.9 
8.7 ± 0.9 
Weight increase 
4.1 ±0 .8 
1.010.5 
0 . 4 1 0.3 
Length, cm 
48.511 .7 
49.7 1 2.2 
65 .512 .4 
71 .712 .4 
74 .412 .5 
kg Length increase, cm 
16.012.1 
6 .411 .2 
2 .411 .1 
!Mean 1 SD; length of 1 infant missing, ** weight of 2 infants missing. 
Nutrition of infants After birth, a large proportion (84%) of the infants received prelacteal 
feeding which in most cases was honey. Also some mothers reported to have given water 
with or without sugar, coffee, biscuit, banana or formula milk. A small proportion (15%) 
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of mothers reported that they discharged part of the first colostrum. All infants but 1 were 
breast-fed after birth and another mother stopped breast-feeding soon after delivery. 
During the first months of life, 80% of the infants were exclusively breast-fed, however 
this proportion decreased rapidly with age (Figure 4.3). The average period of exclusive 
breast-feeding was 1.96 (1.95) months. Almost all women continued breast-feeding their 
infants during the study follow-up (Figure 4.3). The small proportion of mothers that 
breast-fed exclusively or predominantly after 6 months postpartum were mosdy mothers 
that had returned to exclusive or predominant breast-feeding after having tried 
unsuccessfully to introduce food to their infants. Most infants were first introduced to 
liquids, fruit (often banana) and biscuits while foods such as rice, vegetables, tempeh and 
snacks were introduced at a later age (Figure 4.4). From 4 months of age intake of foods 
increased rapidly. Intake of milk products increased during the first 5 months but declined 
thereafter (Figure 4.4). 
Fifteen percent of the infants at 4 months of age did not have a good appetite as 
reported by their mothers and this increased gradually to 50% at 12 months of age. There 
were no significant differences between boys and girls in feeding practices. However, 
compared with mothers of girls, mothers of boys tended to discharge part of the first 
colostrum less often (11% vs. 19%, P =0.073) and give prelacteal feeding less often (79% 
vs. 87%, P =0.067). Boys also tended (P <0.1) to have higher ratios for intake of animal 
products, biscuits and fruit groups (data not shown). 
Figure 4.1 Height-for-age ( • ) , weight-for-age ( • ) and weight-for-height (A) 2-scores of 
infants from 0 to 15 months of age. 
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Figure 4.2 Length of boys ( • ) and girls ( • ) , and weight of boys (A) and girls (X) from 0 
to 15 months of age with growth curve that has been constructed only until 12 months of 
age because thereafter the number of children measured was <100. 
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Figure 4.3 Proportion of infants exclusively breast-fed, predominandy breast-fed, 
complementary fed or non breast-fed at monthly intervals from 0 to 15 months of age. 
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Figure 4.4 Proportion of infants receiving foods from various food groups (as described 
in the methodology section) at monthly intervals from 0 (excluding the prelacteal feeding) 
to 15 months of age. Food groups: animal products (+), biscuits (A), fruit ( • ) , liquid (O), 
milk (#), rice ( • ) , snacks ( • ) , tempeh ( ), vegetables (-). 
0 1 6 7 8 9 
Age, months 
10 11 12 13 14 15 
Figure 4.5 Proportion of infants suffering from selected symptoms of morbidity at 
monthly intervals from 0 to 15 months of age. Morbidity symptoms: running nose ( • ) , 
fever (O), coughing {%), diarrhea ( • ) , vomiting (D ), difficulty breathing (A). 
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Table 4.3 Association of growth and nutritional status with variables of morbidity 
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Partial correlation coefficients controlling for gender; "significant association P <0.01, *P 
<0.05, +P <0.10. 
Morbidity of infants Prevalence of all reported symptoms of morbidity in infants increased 
up 4 to 5 months of age and then remained at a similar level until 12 months of age 
(Figure 4.5). Running nose, fever and coughing were the most reported symptoms of 
morbidity and about 10% of the infants suffered from diarrhoea and/or vomiting. 
Prevalence of ear discharge was rare. Morbidity prevalence was not significandy related to 
season or gender. 
Associations among anthropometry, feeding and morbidity of infants The most prevalent symptoms 
of morbidity, i.e. fever, running nose and coughing, were significandy associated with 
weight increase, and weight-for-age and weight-for-height z-scores (Table 4.3). 
Consumption ratio of the animal products, fruit and biscuits food groups were 
significantly associated with increases in weight and length, and weight-for-age and height-
for-age z-scores while snacks consumption was specifically associated with weight-for-
height z-scores (Table 4.3). Feeding practices such as prelacteal feeding, partly 
discharging first colostrum, or exclusive breast-feeding for >4 months were not associated 
with increases in length or weight, or nutritional status. Infants who had received 
prelacteal feeding suffered more from cough and difficulty breathing and partly 
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discharging first colostrum was associated with difficulty breathing, fever and running 
nose. However, if we corrected these associations for gender, only the association 
between prelacteal feeding and coughing remained significant (data not shown). 
Multiple regression models explained 25% and 36% of the variation in increases of 
weight and of length from 0 to 12 months, respectively, and 25% of weight-for-age, 35% 
of height-for-age and 19% of weight-for-height z-scores at 12 months of age, respectively. 
Maternal weight and height at —18 weeks of pregnancy, housing, and postnatal variables 
such as fever and fruit, biscuits or snacks were of similar strength in predicting increases 
in length and weight and nutritional status of infants (Table 4.4). However, gender and 
especially neonatal weight or length were stronger predictors of increases in length and 
weight and nutritional status of infants. Male gender was associated with lower weight-for-
age and height-for-age z-scores. While neonatal weight and length were negative 
predictors of increases in weight and length respectively, they were positive predictors of 
nutritional status of infants. As also shown in the correlation analysis (Table 4.3), fever 
was negatively associated with weight increase and weight-for-age and weight-for-height z-
scores, but not with length increase and height-for-age z-scores. Neonatal length was a 
stronger predictor of length increase and height-for-age z-scores than neonatal weight for 
weight gain and weight-for-age z-scores (Table 4.4). Height-for-age, weight-for-age, and 
weight-for-height z-scores at 12 months of age were strongly correlated (0.897, 0.947 and 
0.841, respectively; P <0.01), with those at 15 months of age. In addition, models for 
increases in weight and length from 0 to 15 months and nutritional status at 15 months 
were similar to those presented, except that higher maternal education, instead of better 
housing, was a positive predictor in all models. 
Discussion 
Infants in our study began life with reasonable neonatal weight and length while growth 
began to falter around 6-7 months of life. Only a small proportion of the infants was 
wasted but stunting was highly prevalent. The most important determinants of increases in 
weight and length and nutritional status were neonatal weight and length, reflecting 
prenatal factors [19,30]. Maternal factors and postnatal factors were of equal strength in 
predicting growth and nutritional status of infants. 
Growth faltering during the second half of infancy is often seen in Asian populations 
[31,32]. However, infants in our study started growth faltering a few months later and, 
although stunting was highly prevalent at 12 months of age, the proportion of stunting 
was lower than reported earlier in Madurese infants [4]. Once an infant has become 
stunted it will not recover [20] and often height-for-age z-scores remain at the same level 
until 5 years of age [7,32]. Nutritional status of infants at 15 months of age was highly 
correlated with that at 12 months and determinants were similar, indicating that infants 
continued on the same tract into childhood. 
Neonatal weight and length were negatively associated with increases in weight and 
length but positively with z-scores of nutritional status at 12 months of age. Thus, infants 
with lower birth weight experience catch up growth, but they will not achieve the same 
weight or length at 12 months of age, as infants born heavier and longer [33]. This 
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phenomenon of slower growth of initially larger infants is normally seen in developed as 
well as in developing countries [8,34]. In general, boys are taller and heavier than girls 
while lower prevalence of stunting in girls than in boys (23 vs. 27% respectively in our 
population) during the first 1.5 years of age have been reported in other Asian populations 
as well [34]. 
Neonatal length was more predictive of length increase and height-for-age z-scores 
than neonatal weight for weight increase and weight-for-age z-scores. It seems therefore 
that the prenatal environment influenced length more than weight. This is supported by 
the fact that morbidity was associated with weight gain and weight-for-age z-scores but 
not with length increase and height-for-age z-scores. In addition, it is likely that breast 
milk intake protected infants from any long-term growth faltering due to sickness and/or 
decreased nutrient intake [6,35,36]. 
Breast-feeding not only protects infants against infections and diseases but also 
provides psychological advantages [17,34]. Almost all infants were breast-fed until 12 
months of age and received colostrum. However, exclusive breast-feeding was rare in the 
population studied and it declined rapidly from birth to 6 months of age. Exclusive breast-
feeding for >4 months [37] did not show an advantage above complementary or 
predominantly breast-feeding in terms of growth or morbidity. Comparison of the infants 
studied with the 12-months pooled breast-fed data set [11] and the NCHS reference data 
showed that the lower height-for-age and weight-for-age z-scores before 6-7 months of 
age were due to the different growth pattern of breast-fed infants. However, after 6-7 
months the infants studied also started to falter from the reference breast-fed curve. 
Subsequent research has shown that the pattern of growth is not sensitive to the duration 
of breast-feeding [13]. However, we found a small negative association between the 
duration of exclusive breast-feeding and weight-for-height z-scores of the infants studied. 
This effect has also been observed in European infants but was no longer detectable after 
24 months of age [14]. No harmful effects of prelacteal feeding have been reported 
previously in Indonesian infants [33]. However, Vietnamese children that received 
complementary feeding before 3 months of age grew less well and had higher morbidity 
[15] and in the present study a relationship was found between prelacteal feeding and 
coughing. Therefore, we would advice to discourage this habit in line with current 
recommendations for infant feeding [10]. 
Moderate maternal malnutrition does not affect breast milk volume [38] while infant 
growth is not related to energy derived from breast milk [39]. However, micronutrient 
levels in breast milk may play a role in infant growth [4]. Levels of vitamin A and iron in 
breast milk of our mothers were relatively low [26]. Only vitamin A levels of breast milk 
were significantly correlated with increases in weight and length and nutritional status of 
infants. We did not include this variable in our analysis because it greatly reduced the 
number of subjects available for the model. However, if we did include this variable, the 
proportion explained by the models for weight and length increase increased to 32% and 
46%, respectively, with 15 values of 0.131 and 0.201, respectively. 
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Kusin et al. [40] reported that attained weight of Indonesian infants was correlated 
with breast milk intake, but not with food intake. In this study, an association was found 
between intake of certain food groups and increases in weight and length of infants. After 
6 months growth of breast-fed infants may be limited by the micronutrient content of 
complementary foods [12,22]. It may well be that dietary patterns rather than nutrient 
intakes are important in relation to linear growth [7]. In our study, especially fruit, meat 
and biscuits intake were significandy associated with better growth. We only assessed food 
intake of infants qualitatively, but we speculate that food intake may have been 
insufficient to support growth of infants after 7 months. Kusin et al. [33] reported that 
food given to infants might have insufficient energy density. Decreased appetite of infants 
as reported by mothers in our study, may have been due to anorexia as a result of 
morbidity or insufficient micronutrient intake [4,6]. 
Although infants in our study had reasonable neonatal weight and length, meaning 
that prenatal factors were favourable, as compared with for example Indian infants [30], 
neonatal weight and length were still more important determinants of infant growth than 
postnatal factors. Linear growth was less sensitive to postnatal factors such as morbidity 
than increase in weight. In addition, part of infant growth faltering could be attributed to 
maternal nutritional status as has been shown earlier [4,19]. Therefore, it is important not 
only to improve infant nutritional status, but also to ensure that women enter pregnancy 
with good nutritional status. As we reported earlier, infants with adequate vitamin A status 
grew ~1 cm more and gained ~300 g more in the first half year of life than infants with 
marginal vitamin A deficiency [24] (Chapter 3). In all infants vitamin A levels in breast 
milk were associated with growth. Because micronutrient levels in breast milk of the 
mothers of these Indonesian infants were relatively low and also because intake of 
nutrients through food may be inadequate, increasing micronutrient intake of mothers and 
infants through supplements or fortified foods should be considered. Because our models 
explained only one third of growth faltering of infants, other factors such as intake of 
food supplying protein and energy, housing, hygiene and care giving [41] should be 
considered. 
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Mental and psychomotor development of infants of 
mothers supplemented with iron and vitamin A 
during pregnancy in Indonesia 
Marjanka K. Schmidt, Ski Muslimatun, Werner Schultink, Clive E. West and Joseph 
G.A.J. Hautvast 
ABSTRACT Maternal nutrition is important for foetal development but impact on 
functional outcome of infants is still unclear. This study investigated the effects of vitamin 
A and iron supplementation during gestation on infant mental and psychomotor 
development. In addition, associations between maternal vitamin A and iron status during 
pregnancy and infant development were explored. Mothers of infants from 5 villages had 
been randomly assigned on an individual basis to supervised, double blind 
supplementation once weekly from ~18 weeks of pregnancy until delivery. 
Supplementation comprised 120 mg iron and 500 ug folic acid with (n=94) or without 
(n=94) 4800 RE vitamin A. Mothers of infants from 4 other villages who participated in 
the national iron/folic acid supplementation program, but whose intake of supplements 
was not supervised, were also recruited (n=88). Mental and psychomotor development of 
infants was assessed using the Bayley test. Infants were tested either at 6 or 12 months of 
age. Biochemical parameters of mothers were assessed at enrolment, near term and ~4 
months postpartum and of infants at ~4 months of age. We found no impact of 
supplementation with vitamin A during gestation on mental or psychomotor development 
of infants. In addition, infants whose mothers had received weekly iron supplementation 
during pregnancy had similar mental and psychomotor indices as those whose mothers 
had participated in the governmental iron supplementation programme. Infants of 
mothers with adequate vitamin A status near term (n=145) had higher mental 
development indices than infants of mothers with marginal vitamin A status near term 
(n=59). Thus, vitamin A status of mothers during pregnancy would appear to play a role 
in mental development of infants but further research is necessary to test this hypothesis. 
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The importance of nutrition, especially iron, on infant development and the consequences 
for later health have been recognised [1-3]. Studies in humans and animals have shown 
that poor nutrition during gestation may not only impair foetal growth, but also have an 
impact on development during the prenatal period [4-6]. There is evidence for a role of 
iron and possibly of vitamin A in brain development [7-9]. Many studies have shown that 
iron-deficient anaemic infants scored lower on the mental and psychomotor development 
indices of the Bayley test than did iron-sufficient infants [10,11]. An intervention study in 
Indonesia has shown that iron supplementation can improve mental and psychomotor 
development of iron-deficient anaemic infants [12]. 
A large proportion of Indonesian pregnant women suffer from iron deficiency 
anaemia and marginal vitamin A deficiency [13-15]. Iron deficiency anaemia during 
pregnancy is associated with higher risk of low birth weight and pre-term delivery [16]. In 
addition, maternal iron deficiency in pregnancy may reduce foetal and infant iron stores 
[17,18]. Iron status of pregnant women and children have been found to be improved by 
vitamin A supplementation [19,20]. In addition, adequate maternal vitamin A status during 
pregnancy is important for the development of the foetus and to attain sufficient levels of 
vitamin A in breast milk [21]. 
Nutritional status of women postpartum may affect caring capacity and thus mental 
and psychomotor development of their infants [22]. Malnutrition has been related to 
infant development in many trials [23,24], but none has specifically studied the impact of 
vitamin A plus iron supplementation during pregnancy on infant development. 
In Indonesia, iron supplementation during pregnancy is standard practice and thus it 
is not ethical to conduct a study in which pregnant women are not provided with iron 
[25]. However, compliance with supplement intake is found to be low [26] and supervised 
weekly iron supplementation may be an alternative method of choice [27,28]. Hence, iron 
deficiency during gestation may affect iron stores of infants and iron deficiency anaemia 
has adverse effects on infant development, thus it is important to evaluate any new 
regimen of iron supplementation during pregnancy on infant outcome. 
This study investigated whether adding vitamin A supplementation to weekly iron 
supplementation during pregnancy improved mental and psychomotor development of 
infants and whether weekly iron supplementation and the ongoing governmental program 
performed similarly or not with respect to infant development. In addition, the 
relationship between maternal vitamin A and iron status during pregnancy and infant 
development was investigated. 
Methodology 
Study design 
Pregnant women from 9 rural villages in Leuwiliang subdistrict, Bogor district, West Java, 
Indonesia were enrolled in 6 rounds from November 1997 until May 1998 and their 
infants were born from February until November 1998. After birth, all eligible infants 
were followed up monthly up to at least 12 months of age. Mothers of these infants had 
been supplemented with iron and folic acid, either with or without vitamin A, during 
pregnancy or had access to iron plus folic acid tablets through the ongoing government 
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program. Details of the study design and the impact of treatment on maternal biochemical 
status near term and postpartum, breast milk composition, and infant's biochemical status, 
growth and morbidity have been published earlier [27,29-31] (Chapter 2 & 3). Briefly, 
women who were 16-20 weeks pregnant, aged 17-35 years and parity <6, from 5 villages 
were randomly assigned on an individual basis to double-blind, weekly supplementation 
until delivery. Supplementation comprised 120 mg iron as ferrous sulphate and 500 ug 
folic acid or the same amounts of iron and folic acid plus 4800 retinol equivalent (RE) 
vitamin A. Tablet intake was supervised by volunteer health workers and monitored by 
field assistants. Health personal and participants received clear instructions in order to 
avoid additional iron tablet intake. The average period of supplementation in these weekly 
groups was 20 weeks. Women from the other 4 villages, referred to as the 'daily' group, 
were recruited at the same time. These women had free access to iron tablets from the 
health care services following government policy that pregnant women should receive 90-
120 iron/ folic acid tablets, each containing 60 mg iron as ferrous sulphate and 250 ug 
folic acid. Tablet intake in this group was not supervised because this was an effectiveness 
trial comparing the weekly, supervised iron supplementation to the current program. 
Adherence of tablet intake was assessed though interview during a postnatal home visit 
which revealed that the median tablet intake was 50 while only 17% of the subjects took 
>90 tablets [27]. The purpose and procedure of the study were explained to the women at 
enrolment and only women who gave written informed consent were enrolled. The 
Ministry of Health Indonesia and the Ethical Committees of the Medical Faculty at the 
University of Indonesia and Wageningen University approved the research proposal. 
Characteristics of the study population 
Of 366 women recruited at —18 weeks of pregnancy, 318 infants were eligible for follow 
up after birth. Drop out of subjects had occurred because of withdrawal from 
supplementation (n=18), moving outside the research area (n=15), stillbirth (n=l l ) or 
twins (n=3, only 1 infant survived), or neonatal death (n=2) [27,30] (Chapter 2). Mothers 
were interviewed at enrolment for socio-economic background and pregnancy history and 
at a postnatal visit at home for infant food intake and other variables using pre-coded 
questionnaires. 
Development of infants 
Infants were tested for mental and psychomotor development between January and May 
1999 using the Bayley I test [32]. The Bayley test was administered by 2 experienced 
psychologists who had shown previously that the reproducibility between them was high 
(L. Karyadi, personal communication). The psychologists were masked with respect to 
which of the 3 treatment groups the infants belonged. The test had been translated into 
Bahasa Indonesia. Both psychologists were trilingual (Bahahsa Indonesia, Sundanese, and 
English). Half of the infants were tested at 6 (5.5-6.5) months of age and half at 12 (11.5-
12.5) months of age. The tests at 6 months of age were delayed to 7 months in some 
infants because of logistic problems. If an infant was ill, the mother was asked to return to 
enable her infant to be tested at a later session. Tests were administered on the floor in 2 
separate quiet rooms in a house in 1 of the participating villages. 
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The Bayley Mental Scale assesses sensory-perceptual acuity, discrimination and the 
ability to respond to such discrimination; early acquisition of object constancy and 
memory, learning, and problem solving ability; vocalisation and verbal communication; 
and evidence of the ability to generalise and classify [32]. Examples of tests are the infant's 
reaction to sound of bell, dangling a ring, box of blocks, pushing a toy car, or saying 'dada' 
or 'mama'. The Bayley Motor Scale provides a measure of the degree of control of the 
body and the infant's level of maturation in a wide range of gross-motor and fine-motor 
movements [32]. Examples of tests are if the infant is able to role from back to stomach, 
sit independently and pick up blocks or small tablets. From the infant's performance on 
the tests, aggregate scores were calculated, the 'raw' scores, from which age adjusted 
indices of mental development and psychomotor development, were derived. Three 
infants, 1 in each treatment group, had raw mental scores that were too low to be 
converted to the mental development index. These indices were set to 50, the lowest score 
that can be obtained in the mental development index. 
Biochemical measures 
Non-fasting venous blood samples were taken from women (~5 mL) at enrolment, near 
term and ~4 months postpartum and from infants at ~4 months of age (~2 mL) and 
collected in tubes without anticoagulant between 09.00 and 12.00 h. It was not possible to 
obtain blood samples in all cases due to maternal refusal and, in some cases, the amount 
of blood obtained was insufficient for all analyses. Haemoglobin was determined using the 
cyanmethemoglobin method (Test 3317; Merck, Darmstadt, Germany) at the Nutrition 
Research and Development Center laboratory, Bogor. For serum ferritin, soluble 
transferrin receptor and retinol analyses, blood was allowed to clot before it was placed in 
a cool box with cooling elements for transport to the laboratory in Bogor. Blood samples 
were centrifuged at 3000 g for 10 minutes at room temperature and serum was distributed 
among 3 vials. Serum was kept at -20°C for 1 month and subsequendy at -79°C. The 
methods used have been described earlier with all analyses been carried out within 1 year 
of blood collection [30] (Chapter 2). 
Anthropometry 
Weight and length of infants were measured using standardised methods [33]. Weight and 
length of the newborn infant were measured by 2 of the authors (MKS and SM) at the 
time of the postnatal home visit [30] (Chapter 2). Thereafter 2 pairs of trained field 
assistants measured weight and length of infants when their mothers paid the monthly 
visit to the health service post (Posyandu) until 1 year of age. Weight was measured to the 
nearest 50 g by using a baby weighing scale (Misaki, Japan) which was tared each time 
before use. Calibration with a standard weight (5 kg) at regular intervals showed that all 
scales were stable and precise. Recumbent length was measured to the nearest 0.1 cm by 
using a wooden length board [34]. Infants were measured with light clothing. All field 
assistants had received training and were supervised every month by MKS and SM [31] 
(Chapter 3). At enrolment, near term and ~4 months postpartum body weight of the 
mothers was measured to the nearest 0.1 kg by using a UNICEF electronic weighing scale 
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(model 890, SECA, Hamburg, Germany), height to the nearest 0.1 cm using a standing 
height measurement microtoise and mid-upper arm circumference (MUAC) to the nearest 
0.1 cm by using a plastic measuring tape. 
Data analysis 
In the analyses the weekly vitamin A plus iron group was compared with the weekly iron 
group to evaluate the effect of vitamin A supplementation. The weekly iron group was 
compared to the 'daily' group to evaluate the different iron supplementation regimes. In 
addition, the relationship of maternal vitamin A and iron status with development and 
growth of infants was evaluated. Weight and length were converted into z-scores using the 
N C H S / W H O reference data incorporated in the Epi-Info software (Epi Info2000 version 
1.0.5. CDC, Atlanta). Stunting was defined as a height-for-age z-score of <-2, underweight 
as weight-for-age z-score <-2 and wasting as weight-for-height z-score <-2. 
Anthropometric data of infants was grouped into monthly age groups of 0 (0 until 0.99 
months) to 12 (12 until 12.99 months). Comparisons of continuous, normally distributed 
data between groups were done using /-test or ANOVA if correction for other variables 
was necessary. Comparisons of continuous, non-normally distributed data and categorical 
data between groups were done using Mann Whitney U-test and 2C2-test respectively. 
Associations of normally and non-normally distributed data were evaluated using 
Pearson's correlation and Spearman rank correlation respectively. Maternal vitamin A and 
iron status in relation to infant mental and psychomotor development indices was 
evaluated by ANCOVA (GLM procedure). The weekly iron and 'daily' groups did not 
differ with respect to anthropometric and biochemical variables of mothers and infants or 
infant development. Thus, treatment group was defined as having received vitamin A 
supplementation or not (weekly vitamin A plus iron group=l , weekly iron group=0, 'daily' 
group=0). Other variables included were those associated with mental or psychomotor 
indices, i.e. age of infant (6 or 12 months), consultation during pregnancy (as a proxy of 
health conscious behaviour) and maternal age. Birth order was highly correlated with age 
of mothers (r =0.75) and was therefore not included in the model. First, a full factorial 
model was applied and then the not significant interaction terms were excluded from the 
model step by step. Statistical analysis was carried out with the SPSS software package 
(Windows version 10.0.5 SPSS Inc., Chicago, IL). 
Results 
Of the 318 newborn infants initially eligible, 16 infants moved outside the research area 
and 12 infants died during the follow up period from birth to 1 year of age. In addition, 
14 infants did not attend the test because they were sick, their mothers refused or were 
not present. Data are presented of the 276 infants that participated in assessment of the 
Bayley test. More infants were tested at 6 months (n=166) than at 12 months (n=110) of 
age, however, infants from the 2 age groups were evenly distributed over the 3 treatment 
groups (weekly vitamin A plus iron, weekly iron, 'daily'). Infants that were tested did not 
differ with respect to gender, birth order, neonatal weight and length, and maternal age, 
weight, height, biochemical variables, education and housing from those (n=42) that were 
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not tested (data not shown). Except that mothers of infants that were tested had higher 
serum retinol concentrations at enrolment than mothers of infants that were not tested 
(1.00 ± 0.02 versus 0.90 ± 0.04 (Xmol/L, mean ± SE; P <0.05). Mental and psychomotor 
development indices of the Bayley test did not differ between psychologists (Table 5.1). 
One infant could not be tested for the mental test. 
Table 5.1 Comparison of mental and psychomotor development indices of Indonesian 




Mental 'raw' scores 
Mental development index 
Psychomotor 'raw ' scores 
Psychomotor development index 
Psychologist A 
126 
8.5 ± 0.2 
82.8 ± 1.52 
95.2 ± 1.22 
35.9 ± 0.7 
103.1 ± 1.8 
Psychologist B 
150 
8.7 ± 0.2 
81.9 ± 1 . 8 
93.0 ±1 .6 
35.8 ± 0.9 
102.2 ± 1.4 
' M e a n ± S E M , 2 n = 1 2 5 . 
Table 5.2 General characteristics of infants whose mental and psychomotor development 
was assessed using the Bayley test in the weekly vitamin A plus iron, weekly iron and 
'daily' group1 
Infant characteristics 
Boy / girl (n) 
Birth order 
Neonatal weight, kg 
Neonatal length, cm 
Weekly vitamin 
Anaemic: haemoglobin concentrations 
<100 g/L, % (n)2 
Marginal vitamin A deficient: serum retinol 
concentrations <0.70 (Xmol/L, 
Gestational period, weeks 
Maternal characteristics 
Age at enrolment, years 
% (n)2 
A plus iron 
41/53 
1.4 ±0 .1 
3.2 ± 0.1 
49.5 ± 0.2 
31 (68) 
69 (54) 
37.9 ± 0.3 
24.2 ± 0.5 
Weekly iron 
38/56 
1.5 ±0 .1 
3.2 ± 0.1 
49.7 ± 0.2 
29(73) 
80 (60) 
38.5 ± 0.3 
24.1 ± 0.5 
'Daily' 
49/39 
1.7 ± 0 . 2 
3.3 ± 0.1 
49.8 ± 0.3 
28 (68) 
74 (57) 
37.3 ± 0.3* 
24.9 ± 0.5 
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Weight at enrolment, kg 49.2 ± 0.8 
Height at enrolment, cm 149.1 ± 0.6 
Body mass index, kg/m2 22.1 ± 0.3 
Anaemic: haemoglobin concentration <110 g/L, % (n) 
Enrolment 42 (94) 
Near term 40 (77) 
Iron deficiency: serum ferritin concentration <12 |J.g/L, % (n) 
Enrolment 45 (92) 
Near term 55 (76) 
Iron deficiency anaemia: anaemic and iron deficient, % (n) 
Enrolment 16 (92) 
Near term 28 (76) 
• M O T O R D 1 
48.4 ± 0.6 








Marginal vitamin A deficiency: serum retinol concentration <0.70 |Xmol/L, 
Enrolment 12 (92) 
Near term 12(75) 
!
 More than 4 consultations during pregnancy, % 61 
Delivery assisted by traditional birth attendant, % 82 






• V E L O P M E N 1 
49.1 ± 0.8 
149.0 ± 0.5 














Occupation of father, % 
Daily worker (labourer, farmer, driver) 47 50 46 




House with brick wall, tile roof and cemented 
floor, % 67 65 70 
'Data are presented as mean ± SE and n=276, unless stated otherwise; 2Blood samples 
were taken at ~4 months of age; 'Significantly different from the weekly iron group, 
P <0.01 (/-test); **Significandy different from the weekly vitamin A plus iron group, 
P <0.01 (X2-test). 
31 
22 
4.7 ± 0.2 
36 
14 
4.7 ± 0.2 
33 
22 
5.1 ± 0.2 
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General characteristics of the vitamin A plus iron group and the iron group were 
similar as well as the characteristics of the iron group compared with the 'daily' group 
(Table 5.2). Except for a small difference in the gestation period between infants from 
the weekly iron and 'daily' groups. In addition vitamin A deficiency near term was less 
prevalent in mothers in the vitamin A plus iron group than in the other 2 groups, as 
reported earlier [27]. Infants in the weekly vitamin A plus iron group had similar 
development indices as infants in the weekly iron group (Table 5.3). Also the infants in 
the weekly iron group did not differ from infants in the 'daily' group. Mental and 
psychomotor development indices were associated within supplementation and age 
groups (0.427< r <0.706, P <0.05). In addition proportions of infants in the 4 categories 
of the Bayley reference [35] did not differ significantly among groups (Table 5.4). 
Compared with psychomotor development indices, mental development indices were 
lower at 6 months of age but higher at 12 months of age in all treatment groups. Mental 
development indices were higher at 12 months of age than at 6 months of age, whereas 
psychomotor development indices did not differ between both age groups (Table 5.3). 
Mental and psychomotor development indices did not differ between gender. Both indices 
were inversely correlated with age at the 6 months assessment, r =-0.346 and r =-0.260 
(P <0.01) respectively and positively correlated with age at the 12 months assessment, 
r =0.273 and r =0.200 (P <0.05) respectively. 
Mental development indices were significantly (P <0.05) but weakly associated with 
birth order (r =-0.125), maternal age (r =-0.139) and consultation during pregnancy 
(r =0.125) and psychomotor development indices with neonatal length (r =0.120) in all 
infants. None of the other variables presented in Table 5.2 such as education and 
nutritional status of women and occupation of both men and women (94% of the women 
were housewives) were associated with infant development. Mental and psychomotor 
development indices were also not associated with growth during the first year of life (data 
not shown). 
Infants of mothers with serum retinol concentrations >0.70 umol/L at near term had 
significandy higher mental development indices than those of mothers with serum retinol 
concentrations <0.70 umol/L corrected for vitamin A supplementation (yes or no), age of 
infant (6 or 12 months), consultation during pregnancy and maternal age (Table 5.5). The 
association was consistent across all groups. Infants of mothers with serum ferritin 
concentrations <12 |ig/L at near term had significantly higher mental and psychomotor 
development indices than those of mothers with serum ferritin concentrations >12 Hg/L, 
corrected as stated above (Table 5.5). The association was consistent across all groups. 
Neither iron status nor vitamin A status of mothers at enrolment was associated with 
mental or psychomotor development of infants. Infant vitamin A and iron status were not 
associated with mental or psychomotor development indices, except for serum transferrin 
receptors (Table 5.5). 
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Table 5.4 Proportion of infant mental and psychomotor development indices from the 
three treatment groups following the Bayley categories and compared with infants from 
the BSID II reference [351 
BSID II Weekly vitamin A Weekly 
reference plus iron iron 
'Daily' 
ental development index 
Significant delay 
Mild delay 
Within normal limits 
Accelerated 
sychomotor development index 
Significant delay 
Mild delay 
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Discussion 
As far as we know this is the first study to examine the relationship between maternal 
vitamin A and iron status during pregnancy and the impact of supplementation on infant 
development. It has been shown that iodine deficiency in utero negatively affects pregnancy 
outcome and infant development, and there is some evidence for an effect of protein-
energy malnutrition as well [36]. Iron deficiency during infancy has been shown to have 
long term negative consequences for development [1,3]. Although we did not find an 
impact of supplementation, infants of mothers with adequate vitamin A status near term 
had better mental development than did infants of mothers with marginal vitamin A status 
near term. However, it is not clear whether this was due to better caring capacity of 
mothers with better nutritional status [22] or to vitamin A status during pregnancy by 
itself. Although our results suggest that vitamin A plays a role in brain development 
during gestation, we did not prove that maternal vitamin A status is a determinant of 
infant development. Animal studies have shown that retinoic acid is important in 
embryonic development and that highest concentrations are found in the neural tube, 
which is to be developed into the spinal cord and the brain [9]. A study in vitamin A 
deficient pregnant rats showed that vitamin A injection during pregnancy increased brain 
weight relatively to their body weight compared with those that did not receive vitamin A 
[37]. 
Changes in foetal or embryonic development may be subder than can be picked up by 
a mental and psychomotor development test. But it may also be that the moderate degree 
of iron and vitamin A deficiency in the population studied may account for the lack of 
effect of the supplementation [27,31]. Litde is known about the functional outcomes of 
supplementation with micronutrient during pregnancy [38]. One study showed that zinc 
supplementation during pregnancy was found to be negatively associated with mental 
development during infancy [39]. Concerning vitamin A, only 1 study has shown that 
supplementation of infants with vitamin A (52 |Xmol) at birth improved their Bayley 
indices at 3 years of age [40]. 
The different iron treatment regimes, supervised weekly iron supplementation or 
participation in the governmental programme did not lead to differences in mental or 
psychomotor development. Iron deficiency anaemia at early age has been associated with 
development during infancy and childhood [41,42], At ~4 months of age one third of the 
infants studied were anaemic but only 3 were iron deficient [30] (Chapter 2). We only 
found, unexpectedly, that infants with higher serum transferrin receptor concentrations 
(median values as the cut off) had higher mental development indices. Therefore we 
assume that higher serum transferrin receptor concentrations reflected the process of 
erythropoiesis rather than that of mild iron deficiency in these infants [43]. Apparently, at 
least until 4 months of age infants had sufficient iron stores or were protected by iron 
supply from breast milk [44,45]. Almost all infants were breast-fed up to at least 12 
months of age, thus breast milk intake, including essential fatty acids, maternal child 
interaction and reduced morbidity due to breast feeding may have protected the infants in 
our study from retarded development [36,46]. 
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Unexpectedly we found that infants of mothers with adequate iron stores tended to 
have lower mental and psychomotor development indices than did infants of mothers 
with low iron stores near term. However, serum transferrin receptor concentrations, a 
useful indicator for mild iron deficiency during pregnancy and not influenced by infection 
[47], were not associated with infant development. It may be that our finding was due to 
chance, as it is difficult to control for all confounding factors [41]. Three infants had too 
low scores to be converted into the mental development index (indices were set to 50), 
however excluding or including these infants in our data did not change the results. 
Factors such as low socio-economic status, poor maternal education and lack of 
stimulation in the home are both associated with anaemia and poor cognitive 
development [41]. We did not observe an association between maternal education and 
infant development. However, infants of mothers that were not anaemic and/or not iron 
deficient at ~4 months postpartum had consistently but non-significantly higher mental 
and psychomotor development indices than their counterparts (data not shown). 
The Bayley test is widely used to test development of infants [42]. It has however 
been criticised because the predictive value of the scale for later development is small and 
it seems that the concept of 'mental' changes with age [48], as is shown by the difference 
in mental development indices at 6 and 12 months of age in the present study. However, 
studies have shown that the Bayley test can detect differences in development due to 
supplementary feeding in infants [12,49] and children [40]. We assured appropriate use of 
the Bayley test by employing 2 Indonesian psychologists who had much experience with 
using it and who spoke the local language. The indices of the infants studied were in line 
with those in earlier studies in Indonesia and Bangladesh [12,39,40,49] and with the Bayley 
II reference infants [35]. 
In conclusion, mental and psychomotor development of infants did not differ among 
those whose mothers were supplemented with vitamin A plus iron or iron alone, or whose 
mothers participated in the governmental iron supplementation program. From the 
present study there is an indication that vitamin A status of mothers in the third trimester 
of pregnancy, the period in which in growth spurt of the human brain growth [6], plays a 
role in mental development of infants, but further research is necessary to test this 
hypothesis. 
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6 General discussion 
6.1 Introduction 
We investigated the effect of weekly supplementation during gestation with vitamin A 
plus iron compared with iron alone on growth, nutritional status, morbidity, and mental 
and psychomotor development of Indonesian infants. Our hypothesis was that increment 
of nutritional status of pregnant women, would result in improved nutrient stores in 
infants and higher breast milk concentrations of mothers. In addition, we hypothesised 
that this would lead to better growth and health, i.e. a reduction in morbidity and an 
improvement in mental and psychomotor development, of infants. We tested these 
hypotheses in a community-based intervention trial in Indonesian pregnant women, who 
were marginally iron and vitamin A deficient. We also aimed to compare the effectiveness 
of supervised weekly iron supplementation with the ongoing national 'daily' iron 
supplementation programme. We hypothesised that infants of mothers who had been 
supplemented weekly with iron during pregnancy would have higher iron stores and 
nutritional status than infants of mothers who had participated in the national iron 
supplementation programme. To test this hypothesis we recruited a third group of 
pregnant women from neighbouring villages ('daily' group). Our main conclusion is that 
vitamin A plus iron supplementation during gestation did not affect growth, iron status, 
morbidity, or mental or psychomotor development of infants (Chapters 2, 3 & 5). We 
found however that infants of mothers who had been supplemented with vitamin A plus 
iron during pregnancy had higher serum retinol levels at ~4 months of age than those of 
mothers who had been supplemented with iron alone (Chapter 2). Infants of mothers 
who had received weekly iron supplementation during pregnancy did not differ regarding 
any of the variables mentioned above compared with infants of mothers that had been 
participating in the national iron supplementation programme (Chapters 2 & 5). Growth 
faltering of infants started around 6 months of age and led to high prevalence of 
underweight (32%) and stunting (25%) at 12 months of age. Prenatal factors as reflected 
in neonatal weight and length of infants were important determinants of infant growth 
(Chapter 4). 
6.2 Effects of vitamin A supplementation during pregnancy on vitamin A status, 
growth and health of infants 
6.2.1 Vitamin A status and intake of infants 
The present study and a study in Nepal [1] have shown that vitamin A supplementation 
during pregnancy improved vitamin A status of infants at about 3-4 months of age 
(Chapter 2). The difference in serum retinol concentrations of the infants of vitamin A 
supplemented mothers during pregnancy could have resulted from differences in the 
vitamin A stores built up during gestation, from differences in retinol concentrations in 
breast milk, or both [2,3]. It is not yet known to what extent vitamin A is transferred via 
the placenta [2]. We found that concentrations of vitamin A in transitional milk (4-7 days 
postpartum) and mature breast milk (3 months postpartum) were 47% and 17% higher, 
respectively, in the weekly vitamin A and iron group than in the weekly iron group [4]. In 
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agreement with this we found that infant serum retinol concentrations in the weekly 
vitamin A and iron group were 15% higher than in the weekly iron group (Chapter 2). We 
consider therefore that weekly supplementation with 4800 IU vitamin A during the 
second and third trimester of pregnancy made a significant contribution to improving 
vitamin A status of mothers and infants. 
Two earlier studies indicated that placental transfer of vitamin A can be increased if 
women are supplemented with vitamin A. These studies reported that vitamin A 
concentrations in cord blood of infants of mothers supplemented with vitamin A during 
pregnancy were higher than that of their counterparts [5,6]. However, the possible 
contribution of an increased placental transfer of vitamin A is low as compared to that 
supplied via breast milk. Liver samples taken at autopsy from American infants showed 
that median liver concentrations at birth were 11 ug retinol/g wet weight of liver [7]. 
Assuming that a newborn infant of 3.1 kg (Chapter 2) has a liver weight of —150 g (~5% 
of the body weight), the total amount of vitamin A store would be —1650 ug. Normally 
levels of vitamin A in mature milk (>21 d postpartum) are 500-750 ug retinol/L [8]. Thus, 
1 week of exclusive breast feeding, with an intake of about 700 mL breast milk per day 
[9], would transfer more vitamin A to the infant than that transferred via the placenta 
during 9 months gestation. 
The vitamin A requirement of infants is 350 ug (1.2 umol) retinol per day [10]. We 
did not measure intake of breast milk in our infants, because in a pilot study we found 
that it was not feasible. Vitamin A concentrations in transitional milk were reasonably 
high (3.0 ± 2.4 umol/L, mean ± SD) but by 4 months postpartum had declined to 
1.2 ± 0.8 umol/L. At 4 months of age, about 80% of infants were already receiving 
complementary feeding (Chapters 2, 3 & 4), but the effective supply of vitamin A from 
foods was considered low [8,11,12] (Chapters 3 & 4). Thus it is likely that vitamin A 
intake in the infants studied was not sufficient to build up their vitamin A stores. 
The high proportion of infants with serum retinol concentrations <0.70 (Xmol/L 
indicates that vitamin A deficiency constitutes a severe public health problem in this 
population [13]. However these criteria are based on children aged 6-71 mo of age. The 
functional significance of low serum retinol concentrations in young infants is still unclear 
[14]. As far as we know, none of the infants in the present study had signs of vitamin A 
deficiency, and serum retinol levels were within range of values reported in other studies 
[15-17]. A study in which Indian infants were followed up from birth to 6 months of age 
showed significant increases in serum retinol concentrations. In this study 30% of the 
infants had serum retinol concentrations <0.70 umol/L at 6 months of age, although 
none of the infants showed signs of xerophthalmia [18]. 
6.2.2 Growth and health of infants 
Vitamin A supplementation of marginally vitamin A deficient and iron deficient mothers 
during pregnancy did not improve growth or health of infants. The present study found 
however that vitamin A status of infants was positively associated with anthropometric 
parameters of infants during the first year of life (Chapters 2 & 3) and negatively 
associated with respiratory infections at —4 months of age (Chapter 2). This was 
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supported by the finding that vitamin A levels in breast milk were positively associated 
with growth of infants (discussion, Chapter 4). In addition we found a positive association 
between vitamin A status of women near term and mental development of their infants 
(Chapter 5). However, it is not clear whether this was due to better caring capacity of 
mothers with better nutritional status [19] or to vitamin A status during pregnancy by 
itself. Studies that have reported positive effects of vitamin A supplementation on 
morbidity or growth, were carried out in children above the age of 6 months and were 
mostly conducted in areas where vitamin A deficiency was severe [20-24]. The children in 
the present study were younger and the population was 'only' marginally vitamin A 
deficient. In addition, although serum retinol concentrations of infants were increased 
after supplementation of their mothers during pregnancy. This may not have led to a 
sufficient increase in vitamin A status of infants to have a substantial impact on their 
growth and health. Supplementation with vitamin A during pregnancy also did not reduce 
infant mortality in the study in Nepal [1]. While the impact of vitamin A supplementation 
during pregnancy on other functional outcomes needs to be explored further, the large 
reduction in maternal mortality [25], night blindness [26] and anaemia [27,28] justifies 
vitamin A supplementation during pregnancy as long as such supplementation does not 
exceed the advised safe dosage [29]. 
6.3 Effects of iron supplementation during pregnancy on iron status, growth and 
health of infants 
6.3.1 Iron status and intake of infants 
Iron status of mothers during pregnancy or lactation in the present study was not 
associated with iron status of their infants (Chapter 2). Although half of the women were 
anaemic or iron deficient during pregnancy and one fifth had iron deficiency anaemia 
(Chapter 5), the range of the parameters of iron status was relatively small. Studies which 
found a relationship between infant iron status and that of their mothers during 
pregnancy, were those that included women with severe anaemia or with very low iron 
stores (serum ferritin concentrations <10 ug/L) [30,31], or compared supplementation 
with high doses of iron (100 mg per day) with placebo [32]. 
Iron levels in breast milk declined from about 5 days to 3 months postpartum and 
were low compared to populations of developed countries [4]. Although infants in the 
present study were not considered iron deficient at the time of the assessment at 
~4 months of age (Chapter 2). The negative relationship between serum ferritin 
concentrations and age indicates that many infants may become iron deficient by 
6 months of age, unless iron intake is increased. Increased intake of iron may affect 
growth not only by providing sufficient stores, but also by increasing appetite [33]. 
6.3.2 Growth and health of infants 
Because it was considered unethical to include a placebo group in which mothers did not 
receive iron in our study, we cannot draw conclusions regarding the impact of iron 
supplementation on growth and health of infants. However, maternal iron status during 
pregnancy was not associated with infant growth or health in the present study (Chapters 
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2 & 5). The present study did not find any differences between weekly supervised iron 
supplementation and 'daily' iron supplementation in the national program. On the basis 
of infant outcomes (Chapters 2 & 5), there is no justification for recommending one 
regime above the other. This may not be surprising considering that the average amount 
of iron taken in the weekly groups was comparable to that in the 'daily' group, about 40 to 
50 tablets of 60 mg iron. Although iron status of mothers in the 'daily' group who took 
less than 50 tablets decreased during pregnancy [28], this did not lead to differences in 
iron status or growth of infants (Chapter 2). 
The interpretation of haemoglobin concentrations during pregnancy in relation to 
anaemia should be related to the period of gestation because of its association with 
plasma volume expansion. Taking that into account, the relative risk of babies being born 
with low birth weight or preterm tends to show a higher risk only for severe anaemia [34]. 
One study showed that at about 17 weeks of pregnancy iron deficiency anaemia, but not 
anaemia from other causes, was associated with lower birth weight and preterm delivery 
[35]. Folate is critical in foetal development especially of the neural tube and may affect 
pregnancy outcome as well [36]. Because both iron and folic acid are included in the 
supplements, we cannot assess the separate contribution of folic acid or iron on 
pregnancy outcome, but from a public health point of view both should be included. 
The high proportion of mothers that were anaemic or had iron-deficiency anaemia 
postpartum [4] is worrying. Poor maternal nutritional status and especially anaemia may 
lead to less caring capacity and thus may affect development of infants (Chapter 5). As 
shown by others [37-40], iron deficiency anaemia during infancy has a negative effect on 
mental and motor development. However, the effects of iron deficiency during pregnancy 
on infant development have not yet been thoroughly investigated. 
6.4 Growth retardation in infancy 
One third of livebirth infants were born preterm (<37 weeks) but the proportion of low 
birth weights (<2500 g) was small (5.5%). Experienced midwives estimated the gestational 
age of the infants at enrolment and near term by palpation and by asking about the last 
menstruation date. From these assessments and the date of birth, we calculated the 
duration of gestation. Therefore, the estimated proportion of preterm births may not be 
very accurate. Neonatal weight and length were measured within 72 hours only for 20% 
of the infants, therefore, the proportion of low birth weight may be somewhat 
underestimated. However the proportion of infants that were stunted (7%) or 
underweight (5%) at the neonatal assessment was small. The present studies showed that 
growth of infants started to falter during the second half of infancy (Chapter 4) as is often 
reported in other Asian studies [41,42]. By 12 months of age 24% of the infants were 
stunted while 32% of the infants were underweight. The proportions had increased even 
more at 15 months of age (Chapter 4). The reference curves used to determine prevalence 
of stunting have been criticised because they do not reflect growth of breast-fed infants 
and do not include a sufficient sample size [43-45]. A new international reference curve 
for infant and child growth is being prepared currently by the World Health Organisation. 
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During infancy, prevalence of fever, running nose and coughing, was high and 
contributed to growth retardation. Immunisation coverage was found to be inadequate, 
by 1 year of age about half of the infants had completed BCG, D T P and polio 
vaccinations but only about 8% of the infants had completed their immunisation schedule 
which also includes measles and hepatitis. Because almost all infant were breast-fed up to 
12 months of age but exclusive breast-feeding was rare, we did not find a relationship 
between breast-feeding and growth or morbidity of infants. However, intake of 
complementary foods contributed to infant growth. It has been suggested recently that 
not only infant food practices, but also feeding behaviour and stimulation may affect 
infant food intake and thus nutritional status and growth [46,47]. 
The most important determinants of infant growth and nutritional status were 
neonatal weight and length. This suggests that maternal nutrition during pregnancy is 
indeed an important determinant of infant nutritional status and growth. Hence, the 
gestation period or early infancy may be the best time to intervene in order to improve 
growth performance later in life [48]. However, as infant growth is influenced by many 
factors (Chapter 4), interventions directed at infants or their mothers during pregnancy 
may not be effective in improving infant growth. Therefore, the whole life cycle should 
be considered and intervention should start before pregnancy. In addition, deficiencies of 
other micronutrients, besides iron and vitamin A, which could negatively affect growth, 
may be prevalent. Therefore, improving growth of infants may not be achieved by 
increasing intake of only 1 or 2 nutrients during infancy. Existing child health and 
nutrition promotion programs need to be improved and intensified with special attention 
to immunisation coverage, feeding practices and behaviour, and intake of micronutrients. 
6.5 Methodological considerations of the study1 
The aim of this community-based study was to examine the effect of supplementation 
with vitamin A and iron on functional outcomes including pregnancy outcomes, breast 
milk quality, and infant growth and health. It is worth explaining some methodological 
aspects of the whole study [49,50]. 
6.5.1 Inclusion criteria 
It has been found that the efficacy of iron supplementation is proportional to the dose, 
duration of the supplementation and the initial level of iron deficiency [51,52]. An earlier 
study on iron and vitamin A supplementation carried out among anaemic women, in 
which the supplements were administered daily but for a shorter duration, found a higher 
response on haemoglobin concentration [27]. We conducted the study as close as possible 
to the 'real life' setting in the community, therefore women were administered into the 
study irrespective of whether they were suffering from anaemia or deficiencies of iron or 
vitamin A. This would allow us to predict the likely effect of such supplementation at the 
programmatic level, although the intake of supplements was supervised. 
This and subsequent sections of this chapter have been written jointly with Siti Muslimatun and also appear in her 
thesis [49]. 
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6.5.2 Absence of a placebo group and weekly versus 'daily* supplementation 
It was not possible to include a placebo group in this study as this was considered as 
unethical because of government policy that pregnant women should receive 90-120 iron 
tablets throughout pregnancy. We started this study assuming that compliance to iron 
supplementation in the national iron supplementation program ('daily' group) would be 
very low [53]. As has been reported from other studies [53-55], indeed, the compliance 
was poor and the variation in iron tablet intake was large. Only 17% of the women 
ingested the amount as prescribed by the government (>90 tablets), although >95% of 
women received and took iron supplements. 
By including this 'daily' group we aimed to investigate the impact of either low or 
high compliance on improving iron status of pregnant women and their infants. The first 
aim was to measure the comparative effectiveness of the daily and weekly regimens in 
improving iron status of pregnant women. However, it was not possible to address this 
aim fully because of differences in the degree of supervision, which has an effect on 
compliance. The compliance of iron tablet intake in the group allocated to the ongoing 
national iron program ('daily' group) was assessed by interview at the postnatal visit 
whereas the tablet intake in the weekly iron group was strictly supervised. The assessment 
of iron supplement intake in the 'daily' group by means of interview was considered to be 
sufficient as shown by the consistency of changes in iron parameters with the number of 
iron tablets taken during pregnancy. The second aim of the study was to assess the effect 
of low versus high iron tablet intake on maternal iron status and iron status of newborn 
infants. However, this aim could not be addressed satisfactorily. Although there was a 
wide variation in tablet intake, the number of subjects with either a high (>90) or low 
(<30) intake of tablets was insufficient. In order to have a reasonable number of subjects 
with different levels of compliance, the number of subjects in the 'daily' group should 
have been 5-6 times larger based on the observation that only one fifth of the pregnant 
women consumed between 90 and 120 tablets as is the policy. 
6.5.3 Attendance rate and loss to follow-up 
High attrition (20-45%) is commonly observed in prospective community-based studies 
of pregnant women. This can be due to either non-attendance or early delivery. In our 
study, 26% and 38%, in the weekly groups and 'daily' group respectively, of pregnant 
women did not come for the near term assessment, whereas the proportion of pregnant 
women having antenatal care <4 times (including 2 times for study assessment) were 38% 
and 35%, respectively. However, only 7.4% of women in the weekly groups withdrew 
during pregnancy. The difficulty of reaching pregnant women is also reflected in the 
relatively long delay in reporting birth of babies, particularly from the 'daily' group. 
Neonates in the 'daily' group were measured later than those in the weekly groups 
(6.9 ± 3.7 versus 5.2 ± 3.3 days, P <0.05; mean ± SD). Continuous motivation and 
conducting the assessment closer to their place of residence improved the attendance, as 
shown by low prevalence of lost to follow-up during infancy, 9% and 8% in the weekly 
groups and 'daily' group, respectively. 
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6.5.4 Indonesian crises 
The economic crisis in Indonesia and other Southeast Asian countries started 3 months 
prior to the start of the fieldwork in October 1997. Between October 1997 and January 
1998 the exchange rate of the Indonesian Rupiah against the US Dollar increased from 
3845 to 17000. In one year the per capita growth in Gross Domestic Product declined 
from +3.3% to —14.8% [56]. The crisis increased the number of people in poverty by 
about 13 million. Inevitably, the increased price of basic commodities and food had 
compromised the consumption of meat, eggs, cooking oil and sugar, although rice 
consumption did not decrease substantially [57]. Hence, iron status may have decreased 
due to the lower intake of animal foods. Fortunately, the design of our study was such 
that if the crisis had affected the nutritional status of the women or infants, this would 
not have influenced the comparisons made and the conclusions that can be drawn from 
the study. Unfortunately we have no data to show the impact of the crisis on the 
nutritional status of our study population or on coping strategies of households. 
6.6 General conclusions 
The present study [49,50] demonstrated that weekly supplementation with iron and 
vitamin A during the gestation period improved the serum retinol concentration of 
women during pregnancy and of their infants at about 4 months of age and retinol 
concentration in breast milk. However, supplementation with vitamin A and iron did not 
reduce the prevalence of anaemia during pregnancy and did not affect growth, iron status, 
morbidity, or mental or psychomotor development of infants. 
The study also showed that neither the weekly iron supplementation nor the 
governmental iron supplementation program improved the iron status of the pregnant 
women. In addition, there were no differences between the 2 treatment groups with 
respect to iron status, nutritional status, or development of infants. 
Almost half of the women were anaemic and had low iron stores during pregnancy 
and lactation indicating a problem of public health significance. Although infants in the 
present study were not considered iron deficient at about 4 months of age. Based on the 
negative correlation between age and serum ferritin concentrations and decreasing iron 
levels in breast milk, it may be expected that many infants had become iron deficient by 6 
months of age. On the basis of the mean concentration of retinol in serum and in breast 
milk and the prevalence of marginal vitamin A status (serum retinol concentration <0.70 
umol/L), the vitamin A status of pregnant and lactating women could be considered as 
marginal. Hence, vitamin A intake from breast milk was probably too small to build up 
adequate stores in infants. In addition, a large proportion of infants had a serum retinol 
concentration <0.70 umol/L. Criteria for defining inadequate vitamin A status however 
are based on children 6-71 months of age. Hence, the functional significance of low 
serum retinol concentrations in young infants is still unclear. 
Although the neonatal weight and length were considered as satisfactory, growth 
faltering of infants started at about 6 months of age, and a large proportion had become 
stunted (24%) and underweight (32%)) by 12 months of age. Gestational age and maternal 
weight were the predictors of neonatal weight and length, whereas neonatal weight and 
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length were important determinants of infant growth and nutritional status. This suggests 
that maternal nutrition during pregnancy is indeed an important determinant of infant 
nutritional status and growth. However, as infant growth is influenced by many factors, 
interventions directed at infants or their mothers during pregnancy may not be effective 
in improving infant growth. Therefore, the whole life cycle should be considered and 
intervention should start before pregnancy. 
6.7 Implications 
Although the programmatic issues, such as availability of supplements, accessibility, and 
compliance of prenatal iron supplementation for the prevention of anaemia need to be 
resolved further, the inclusion of vitamin A in iron supplementation should be 
considered. In this study, pregnant women were supplemented with 4800 RE vitamin A 
together with 120 mg elemental iron and 500 ug folic acid weekly. However, the dose of 
vitamin A might be increased up to 7500 RE [29]. N o congenital malformations were 
observed in any of the infants born during the study. In a study in Nepal [25] using a dose 
of 7000 RE, no malformations were reported neither. The delivery of vitamin A and iron 
supplements should be incorporated in a safe motherhood programme, which among 
other measures to improve the programme should aim at increasing the number of 
deliveries assisted by trained health workers. The inclusion of vitamin A in the iron 
supplement did not appear to influence iron bioavailability [Annex of 49]. However, the 
shelf life of vitamin A in the non-oil-based supplement needs to be addressed carefully 
because of its vulnerability to losses during storage. 
The delivery of iron-folk acid supplements on a weekly basis for the prevention of 
anaemia among pregnant women is not an alternative solution to overcoming the low 
effectiveness of the current iron supplementation programme. In order to prevent 
anaemia and iron deficiency during pregnancy, daily iron supplementation during 
pregnancy needs to be continued beyond birth provided that the compliance is improved 
and side effects due to iron tablet ingestion are reduced. Iron supplements in different 
preparations such as those based on the gastric delivery system or on ferrous fumarate 
may reduce gastrointestinal problems. Besides efficacy and effectiveness of the 
supplementation, affordability in the country or area to implement the program needs to 
be tested. In addition, other causes of anaemia should be elucidated and quantified. 
Immunisation coverage was found to be low and few infants were exclusively breast-
fed. In addition, vitamin A and possibly iron intake of infants needs to be increased. 
Existing child health and nutrition promotion programs need to be improved and 
intensified with special attention to immunisation coverage, feeding practices, and intake 
of micronutrients. 
While pharmanutrient supplementation is an effective way to improve the 
micronutrient status of a population, other solutions such as food based approaches, 
either with natural, enriched or fortified foods, need to be integrated in striving towards 
the elimination of micronutrient deficiency disorders. 
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6.8 Future research 
In order to elucidate the role of iron and vitamin A in foetal development, including the 
neurological development, basic cellular and molecular research should be directed at the 
transfer mechanisms of iron and vitamin A from mothers to infants and factors 
associated with its mechanisms. 
Three important factors for an effective nutrient supply are the availability of foods 
rich in the respective nutrient, the content of the respective nutrient in food, and 
bioavailability or bioefficacy of respective nutrient for the bodily function. On the short 
term, advocating increased intake of supplements for mothers and infants is necessary to 
improve their nutritional status. However, longer-term solutions, such as identifying easy 
accessible foods rich in iron and vitamin A, or food enrichment by plant breeding or 
fortification, need to be addressed. 
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Summary 
In Indonesia, many infants and children are undernourished as is illustrated by the high 
prevalence of stunting and micronutrient deficiencies. Nutrition during pregnancy is 
important for women's health, pregnancy outcome, and infant growth and health. 
Vitamin A and iron are important nutrients for foetal development and for infant growth, 
immunity and development. Vitamin A plays a role in iron metabolism and has been 
shown to reduce anaemia in vitamin A deficient pregnant women. In Indonesia, half of 
the pregnant women suffer from iron deficiency anaemia whereas one third of pregnant 
and lactating women are marginally vitamin A deficient. In Indonesia iron 
supplementation during pregnancy is standard practice and thus it is not ethical to 
conduct a study in which pregnant women are not provided with iron. However, 
effectiveness of the national daily iron supplementation programme has been shown to be 
low. Weekly iron supplementation has been proposed as a method of choice for 
providing iron supplements. 
The aim of the present study was to investigate whether weekly supplementation with 
iron and vitamin A of pregnant women improves growth and health of their infants. 
Improvement of health was defined as a reduction in morbidity and an improvement of 
mental and psychomotor development. The impact of supplementation with iron and 
vitamin A on nutritional status of women during pregnancy and lactation are described in 
the complementary thesis entitled 'Nutrition of Indonesian women during pregnancy and 
lactation: a focus on vitamin A and iron' by Siti Muslimatun. 
From November 1997 until November 1999, we conducted a community-based 
study in 9 rural villages in Leuwiliang subdistrict, Bogor district, West Java, Indonesia, in 
which women were recruited who were aged 17-35 years, parity <6, 16-20 weeks pregnant 
and had haemoglobin concentrations 80-140 g/L. Women from 5 villages were randomly 
assigned on an individual basis to supervised, double-masked supplementation once 
weekly from enrolment until delivery. Supplementation comprised 2 tablets each 
containing 60 mg elemental iron as ferrous sulphate and 250 ug folic acid with or without 
2400 RE vitamin A. Subjects from the other 4 villages were assigned to a third group, 
referred to as the 'daily' group. These subjects were participating in the ongoing national 
iron supplementation programme and received iron/folic acid tablets through medical 
services. These tablets were similar in appearance and in iron and folic acid composition 
to the tablets administered weekly. Intake of iron tablets was not supervised. Initially 366 
women were enrolled. Their newborn infants were followed up at least until 1 year of age. 
Subjects were considered to have dropped out when they withdrew from the study, 
moved outside the research area, or had twins, stillbirth or infant death. Non attendants 
were not considered lost to follow up. 
Firstly, we investigated whether vitamin A and iron supplementation during gestation 
affected vitamin A and iron status of infants. In Chapter 2, we present data from infants 
(n=222) from whom sufficient blood was drawn for the assessment of haemoglobin 
concentration at ~4 [3.7 (1.9-6.3), mean (range)] months of age. Infants in the weekly 
vitamin A plus iron group had significantly higher serum retinol concentrations than 
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infants in the weekly iron group (0.62 ± 0.02 versus 0.54 ± 0.02 umol/L, mean ± SE). 
Serum retinol concentrations did not differ between the weekly iron and 'daily' groups. In 
all groups >70% of the infants had serum retinol concentrations <0.70 umol/L. Iron 
status was similar in all groups. The proportion of infants with a haemoglobin 
concentration <100 g /L was 29% while only 3 infants had a serum ferritin concentration 
<12 ug/L. Iron status of infants did not differ between mothers in the 'daily' group who 
had taken <50 tablets and those who had taken >50 tablets during pregnancy. Serum 
retinol concentrations of infants were correlated with those of their mothers at 
~4 months postpartum in all groups (r =0.374, P <0.01) and at enrolment in the weekly 
iron and 'daily' groups. None of the variables of iron status of mothers during pregnancy 
was associated with iron status of their infants. Serum retinol concentrations of mothers 
~4 months postpartum, upper respiratory tract infection and vitamin A supplementation 
showed the strongest association with serum retinol concentrations in infants. 
Secondly, we investigated whether vitamin A and iron supplementation during 
gestation had an impact on growth or morbidity of infants until 12 months of age. In 
Chapter 3, we present data from infants, in the weekly vitamin A and iron (n=107) and 
weekly iron (n=105) groups, who were eligible for follow up after birth, and who attended 
at least once the monthly anthropometric assessments at the health post. Length, weight 
and growth, and incidence and prevalence of selected symptoms of morbidity of infants, 
whose mothers had been supplemented with vitamin A during gestation, did not differ 
from that of their counterparts at any age during the first year of life. Breast-feeding 
prevalence and immunisation coverage were similar in both groups, but only 6.7% of the 
infants had already completed the immunisation schedule. During the first 6 months of 
life, infants with serum retinol concentrations >0.70 (Xmol/L increased their weight and 
length more and had higher z-scores for height-for-age than those with serum retinol 
concentrations <0.70 |J.mol/L, but had similar prevalence of morbidity. 
In Chapter 4, growth patterns and determinants of growth and nutritional status of 
infants from the 3 treatment groups were investigated using data of 151 boys and 167 
girls who were available for follow up after birth. Most of the increase in length and 
weight of infants occurred during the first 6 months of life. At the neonatal assessment 
only 7% of the infants were stunted, 5% were underweight and none were wasted. This 
situation was similar at 6 months of age. Thereafter growth started to falter. At 12 months 
of age, 24% were stunted, 32% underweight and 4% wasted, while in the subgroup that 
was followed up until 15 months of age these proportions had increased even more. Boys 
had higher weight and length than girls from 0 to 15 months of age, although nutritional 
status (z-scores) did not differ significantly between boys and girls. During the first month 
of life, 80% of the infants received breast milk only ('exclusively breast-fed'), however the 
intake of complementary foods increased rapidly with age. Almost all women continued 
breast-feeding their infants during the study follow up. Running nose, fever and coughing, 
which were the most reported symptoms of morbidity, were significantly associated with 
smaller weight increase and z-scores. Consumption of the food group of animal products, 
fruit and biscuits were significandy associated with higher increases in weight and length, 
and z-scores. Feeding practices such as prelacteal feeding, partly discharging first 
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colostrum, or 'exclusive' breast-feeding for >4 months were not associated with growth or 
nutritional status. In multiple linear regression, neonatal weight and length, reflecting 
prenatal factors, were the strongest predictors of growth and nutritional status of infants 
at 12 months of age. In addition, maternal weight and height at ~18 weeks of pregnancy, 
housing, and postnatal variables such as intake of certain food groups and morbidity were 
predictors of growth and nutritional status of infants at 12 months of age. 
We also investigated whether vitamin A and iron supplementation during gestation 
improved mental and psychomotor development of infants (Chapter 5). Infants (n=276) 
were tested using the Bayley test either at 6 or at 12 months of age, and these age groups 
were evenly distributed over the 3 treatment groups. Mental and psychomotor 
development of infants whose mothers were supplemented weekly with vitamin A plus 
iron during pregnancy was similar to those whose mothers were supplemented with 
weekly iron alone. In addition, infants of mothers supplemented with weekly iron during 
pregnancy performed similar to those whose mothers had participated in the national iron 
supplementation program. Mental development index scores were significantly (P <0.05) 
but weakly associated with maternal age (r =-0.139) and the number of times a mother 
had a check up during pregnancy (r =0.125). Correcting for these confounders, and for 
age and treatment group, infants of mothers with serum retinol concentrations >0.70 
umol/L at near term had significantly higher mental development index scores than those 
of mothers with serum retinol concentrations <0.70 umol/L. However, it is not clear 
whether this was due to better caring capacity of mothers with better nutritional status or 
to vitamin A status during pregnancy by itself. 
In conclusion, the present study showed that vitamin A supplementation during 
gestation improved vitamin A status of infants at ~4 months of age. The difference in 
serum retinol concentrations of infants of vitamin A supplemented mothers during 
pregnancy compared with their counterparts could have resulted from differences in the 
vitamin A stores built up during gestation, from differences in retinol concentrations in 
breast milk, or both. However, vitamin A supplementation had no impact on growth or 
health, as indicated by morbidity and mental or psychomotor development, of infants. 
Considering the association of vitamin A status with growth of infants and the high 
prevalence of marginal serum retinol concentrations, an increased intake of vitamin A 
during infancy may be beneficial. Infants whose mothers were supplemented weekly with 
iron during pregnancy did not differ in any of the mentioned parameters from those 
whose mothers participated in the national iron supplementation program. Thus on the 
basis of outcomes on the infants there is no justification for recommending one regime 
above the other. At ~4 months of age, none of the infants suffered from iron deficiency 
anaemia but infants may have become iron deficient at later age. Growth faltering of 
infants started around 6 months of age and led to high prevalence of underweight and 
stunting at 12 months of age. The most important determinants of infant growth and 
nutritional status were neonatal weight and length. Hence, the gestation period or early 
infancy may be the best time to intervene in order to improve growth performance later 
in life. Incorporation of vitamin A supplementation in the health care program for 
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pregnant women in Indonesia should be considered. However, in order to optimise 
nutritional status and growth of infants the whole life cycle should be considered. 
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Samenvatting 
Nog steeds zijn veel baby's en kinderen in Indonesie ondervoed, hetgeen blijkt uit de 
hoge prevalentie van groeiachterstand en micronutrientendeficienties. Voeding tijdens de 
zwangerschap is niet alleen van belang voor de gezondheid van de moeder, maar ook 
voor een goede ontwikkeling van de foetus en een goede groei en gezondheid van de 
baby. Vitamine A en ijzer zijn twee van de belangrijkste nutrienten voor een goede 
ontwikkeling van de foetus en voor groei, immuniteit en ontwikkeling van de baby. 
Vitamine A heeft een functie in het ijzermetabolisme en er is aangetoond dat vitamine A-
suppletie de prevalentie van anemie bij vitamine A-deficiente, zwangere vrouwen kan 
reduceren. De helft van de zwangere vrouwen in Indonesie lijdt aan ijzerdeficientie 
anemie terwijl eenderde marginale vitamine A-deficientie heeft. In Indonesie is 
ijzersuppletie voor zwangere vrouwen reeds standaardpraktijk. Het zou daarom onethisch 
zijn geweest een studie uit te voeren met een ijzer-placebo groep. De effectiviteit van het 
nationale programma, waarin ijzersuppletie dagelijks genomen moet worden, is echter 
laag. Daarom werd wekelijkse ijzersuppletie gekozen als een voorkeursmethode om 
zwangere vrouwen van voldoende ijzer te voorzien. 
Het doel van de huidige studie was te onderzoeken of wekelijkse ijzer- en vitamine A-
suppletie van zwangere vrouwen de groei en gezondheid van hun baby's zou verbeteren. 
Een betere gezondheid werd gedefinieerd als een reductie in het voorkomen van ziekten 
en een betere mentale en motorische ontwikkeling. Het effect van ijzer- en vitamine A-
suppletie op de voedingsstatus van de vrouwen gedurende de zwangerschap en lactatie 
zijn door Siti Muslimatun beschreven in een complementair proefschrift getiteld 
'Nutrition of Indonesian women during pregnancy and lactation: a focus on vitamin A 
and iron'. 
Van november 1997 tot november 1999 voerden we een studie uit in 9 rurale dorpen 
in Leuwiliang subdistrict, Bogor district, West Java, Indonesie. Voor deze studie werden 
vrouwen gerekruteerd die voldeden aan de volgende criteria: 17-35 jaar oud, pariteit <6, 
16-20 weken zwanger en een hemoglobineconcentratie van 80-140 g/L. Vrouwen uit 
5 dorpen kregen aselect supplementen voorgeschreven die bestonden uit 2 tabletten die 
elk 60 mg elementair ijzer als ijzersulfaat en 250 ug foliumzuur bevatten, met of zonder 
2400 RE vitamine A. De suppletie moest een maal per week genomen worden vanaf het 
moment van inschrijving tot de bevalling. Om de inname van de supplementen te 
verzekeren, gebeurde dit onder supervisie. Een derde groep werd gevormd door vrouwen 
uit de andere 4 dorpen, die de 'dagelijkse' groep wordt genoemd. Deze vrouwen konden 
participeren in het nationale ijzersuppletieprogramma en ontvingen ijzer/foliumzuur-
tabletten via de reguliere medische kanalen. Deze tabletten zagen er hetzelfde uit en 
hadden dezelfde ijzer- en foliumzuursamenstelling als de tabletten die genomen werden in 
de wekelijkse groepen. De inname van tabletten in de 'dagelijkse' groep gebeurde echter 
niet onder toezicht. Aanvankelijk schreven zich 366 vrouwen in voor de studie. De 
pasgeboren baby's van deze vrouwen werden gevolgd totdat ze tenminste 1 jaar oud 
waren. Wanneer vrouwen zich terugtrokken uit de studie, verhuisden naar buiten het 
onderzoeksgebied, een tweeling of een doodgeboren kind kregen of als de baby overleed, 
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vielen zij af en konden niet meer met het onderzoek meedoen. Echter, vrouwen die 
afwezig waren bij een of meer metingen mochten blijven meedoen tot het einde van het 
onderzoek. 
Als eerste hebben we onderzocht of vitamine A- en ijzersuppletie tijdens de 
zwangerschap invloed had op de vitamine A- en ijzerstatus van de baby's. In hoofdstuk 2 
presenteren we daarvoor de gegevens van de baby's (n=222) waarvan voldoende bloed 
kon worden afgenomen voor een bepaling van de hemoglobineconcentratie op de leeftijd 
van ~4 maanden [3.7 (1.9-6.3), gemiddelde (spreiding)]. Baby's wiens moeders wekelijks 
pillen met vitamine A en ijzer hadden genomen, hadden een significant hogere 
retinolconcentratie in hun serum dan baby's wiens moeders wekelijks alleen ijzer had 
genomen (0.62 ± 0.02 versus 0.54 ± 0.02 umol/L, gemiddelde ± standaardfout). De 
retinolconcentratie in serum verschilde niet tussen de groepen die wekelijks of 'dagelijks' 
alleen ijzer hadden genomen. In alle 3 de groepen had meer dan 70% van de baby's een 
retinolconcentratie in serum <0.70 umol/L. Ijzerstatus van de baby's was hetzelfde in alle 
groepen. Het percentage baby's met een hemoglobineconcentratie <100 g /L was 29%, 
terwijl slechts 3 baby's een ferritineconcentratie in serum <12 ug /L hadden. Ijzerstatus 
van baby's in de 'dagelijkse' groep van wie de moeders <50 tabletten hadden geslikt 
verschilde niet van de baby's van wie de moeder >50 tabletten hadden geslikt tijdens hun 
zwangerschap. De retinolconcentratie in serum van de baby's was gecorreleerd met die 
van hun moeders ~4 maanden na de bevalling in alle groepen (r =0.374, P <0.01) en 
tevens met die van hun moeders tijdens de zwangerschap op het moment van inschrijving 
in de groepen die wekelijks en 'dagelijks' alleen ijzer hadden genomen. Er was geen 
correlatie tussen de ijzerstatus van de baby's en die van hun moeders tijdens de 
zwangerschap. Retinolconcentraties in serum van de baby's was het meest gerelateerd aan 
retinolconcentraties in serum van hun moeders ~4 maanden na de bevalling, bovenste 
luchtweginfecties bij de baby's en vitamine A-suppletie. 
Ten tweede hebben we onderzocht of vitamine A- en ijzersuppletie tijdens de 
zwangerschap leidde tot betere groei en een reductie in het voorkomen van ziekte van de 
baby's tot 12 maanden oud. In hoofstuk 3 presenteren we de gegevens van de baby's, in 
de wekelijkse vitamine A en ijzer (n=107) en wekelijkse ijzer (n=105) groepen, die gevolgd 
konden worden vanaf de geboorte en die tenminste een keer aanwezig waren geweest bij 
de maandelijkse antropometriemeting op de gezondheidspost. Gedurende het eerste 
levensjaar waren er geen verschillen in lengte, gewicht en groei, en incidentie en 
prevalentie van geselecteerde ziektesymptomen tussen de baby's wiens moeders vitamine 
A-suppletie hadden genomen tijdens de zwangerschap en de baby's wiens moeders geen 
vitamine A hadden gekregen. Prevalentie van borstvoeding en immunisatiedekking waren 
vergelijkbaar tussen de groepen, maar slechts 6.7% van de baby's had reeds het volledige 
vaccinatieschema afgerond. Tijdens de eerste 6 levensmaanden hadden baby's met 
retinolconcentraties in serum >0.70 (Xmol/L meer gewicht- en lengtetoename en hogere 
z-scores voor lengte-voor-leeftijd dan degenen met retinolconcentraties in serum 
<0.70 |J.mol/L, maar de prevalentie van ziektesymptomen was vergelijkbaar. 
In hoofdstuk 4 worden groeicurven en determinanten van groei en voedings status 
van baby's in de 3 behandelingsgroepen gepresenteerd. Voor deze groeicurven en de 
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bepaling van de determinanten werd gebruik gemaakt van de gegevens van 151 jongens 
en 167 meisjes die vanaf hun geboorte gevolgd waren. Lengte en gewicht van de baby's 
namen het meest toe tijdens de eerste 6 levensmaanden. De neonatale meting (de eerste 
meting na de geboorte) liet zien dat slechts 7% van de baby's een groeiachterstand had, 
5% had ondergewicht en geen enkele baby was ondervoed. Bij de meting van de baby's 
toen ze 6 maanden oud waren was de situatie niet veranderd. Op de leeftijd van 6 tot 7 
maanden begon de groei echter af te nemen. Bij de meting van de baby's toen ze 
12 maanden oud waren had 24% een groeiachterstand, 32% ondergewicht en was 4% 
ondervoed, terwijl in de subgroep van baby's die tot 15 maanden oud gevolgd waren deze 
percentages zelfs nog waren toegenomen. Van 0 tot 15 maanden waren jongens zwaarder 
en langer dan meisjes, hoewel de voedingsstatus (z-scores) tussen beiden niet significant 
verschilde. Tijdens de eerste maand na de geboorte kreeg 80% van de baby's alleen 
borstmelk ('exclusieve' borstvoeding) maar met toenemende leeftijd nam het percentage 
dat complementaire voeding kreeg snel toe. Bijna alle vrouwen bleven hun baby 
borstvoeding geven gedurende de studie. Verkoudheid, koorts en hoest bij de baby's, de 
ziektesymptomen die het meest door hun moeders gerapporteerd werden, waren 
significant gerelateerd aan een kleinere gewichtstoename en lagere z-scores. Consumptie 
van de voedselgroepen van dierlijke producten, fruit en biscuit was significant gerelateerd 
aan een grotere gewichtstoename en hogere z-scores van de baby's. Voedingspraktijken 
zoals het geven van prelactale voeding, het gedeeltelijk weggooien van het eerste 
colostrum of 'exclusieve' borstvoeding gedurende >4 maanden waren niet geassocieerd 
met groei of voedingsstatus. Met behulp van multipele lineaire regressie werd gevonden 
dat neonataal gewicht en lengte, die indicatief zijn voor prenatale factoren, de 
belangrijkste voorspellers van groei en voedingsstatus van baby's op de leeftijd van 
12 maanden waren. Daarnaast werd groei en voedingstatus van baby's van 12 maanden 
oud voorspeld door gewicht en lengte van de moeder tijdens de ~18 d e week van de 
zwangerschap, de woonsituatie en postnatale variabelen, zoals de consumptie van 
bepaalde voedselgroepen en het voorkomen van ziektesymptomen. 
We hebben ook onderzocht of vitamine A- en ijzersuppletie tijdens de zwangerschap 
leidde tot een betere mentale en motorische ontwikkeling van de baby's (hoofdstuk 5). 
Op de leeftijd van 6 of 12 maanden werden de baby's (n=276) getest met de Bayley test. 
Beide leeftijdsgroepen waren gelijk verdeeld over de 3 behandelingsgroepen. De mentale 
en motorische ontwikkeling van de baby's wiens moeders wekelijks vitamine A- en 
ijzersuppletie hadden genomen, was vergelijkbaar met de baby's wiens moeders wekelijks 
alleen ijzer hadden genomen. Daarnaast was er geen verschil tussen de baby's wiens 
moeders wekelijks ijzer hadden genomen en de baby's wiens moeders hadden 
deelgenomen aan het nationale ijzersuppletieprogramma. Mentale ontwikkelingsindices 
waren significant (P <0.05) maar zwak geassocieerd met de leeftijd van de moeder 
(r =-0.139) en het aantal keer dat de moeder een controleonderzoek had laten uitvoeren 
tijdens haar zwangerschap (r =0.125). In de analyse werd gecorrigeerd voor deze 
variabelen en voor de leeftijd van de baby en de behandelingsgroep. Baby's wiens 
moeders aan het eind van de zwangerschap een retinolconcentratie in serum 
>0.70 umol/L hadden, hadden significant hogere mentale ontwikkelingsindices dan 
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baby's wiens moeders een retinolconcentratie in serum <0.70 umol/L hadden. Het is 
echter niet duidelijk of dit verschil te danken is aan een verschil in zorgcapaciteit van de 
moeders of aan de vitamine A-status tijdens de zwangerschap zelf. 
Concluderend kunnen we stellen dat de huidige studie heeft aangetoond dat vitamine 
A-suppletie tijdens de zwangerschap kan leiden tot een verbeterde vitamine A-status van 
baby's op een leeftijd van 4 maanden. Het verschil tussen de retinolconcentratie in serum 
van de baby's wiens moeders wel en niet vitamine A hadden genomen tijdens de 
zwangerschap, kan een gevolg zijn van een verschil in vitamine A-voorraden opgebouwd 
tijdens de zwangerschap, van een verschil in retinolconcentratie in borstmelk, of van 
beiden. Vitamine A-suppletie had echter geen invloed op de groei van de baby's of op 
hun gezondheid, die werd gemeten als het voorkomen van ziektesymptomen en de 
mentale en motorische ontwikkeling. De associatie tussen vitamine A-status en groei van 
baby's en de hoge prevalentie van marginale vitamine A-concentraties in serum in 
aanmerking nemend, zou een verhoogde inname van vitamine A tijdens het eerste 
levensjaar gunstig voor de gezondheid kunnen zijn. Baby's wiens moeders wekelijks 
ijzersuppletie hadden genomen tijdens de zwangerschap verschilden in geen van de 
genoemde parameters van de baby's wiens moeders hadden deelgenomen aan het 
nationale ijzersuppletieprogramma. Op basis van de gegevens over de groei en 
gezondheid van de baby's kan dan ook geen voorkeur worden uitgesproken voor een van 
de 2 regimes. O p de leeftijd van ~4 maanden oud had geen van de baby's ijzerdeficientie 
maar dit was mogelijk wel het geval op latere leeftijd. Op de leeftijd van 6 maanden begon 
de groei van de baby's te stagneren hetgeen leidde tot een hoog percentage baby's op de 
leeftijd van 12 maanden met ondergewicht en groeiachterstand. De belangrijkste 
voorspellers van groei en voedingstatus van de baby's waren hun neonatale gewicht en 
lengte. Daarom zou de zwangerschap of het begin van het eerste levensjaar de beste 
periode zijn voor een interventie die kan leiden tot betere groei op latere leeftijd. Het zou 
overwogen moeten worden om vitamine A-suppletie in te bedden in het 
gezondheidszorgprogramma voor zwangere vrouwen in Indonesie. Om echter een 
optimale voedingstatus en groei van baby's te bereiken zou de hele levenscyclus in 
beschouwing genomen moeten worden. 
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Ringkasan 
Masih banyak bayi dan anak-anak yang kekurangan gizi seperti tampak dari tingginya 
prevalensi stunting (kurang tinggi menurut umur) dan kekurangan gizi mikro di Indonesia. 
Gizi selama kehamilan penting bagi kesehatan ibu, kualitas kehamilan, dan pertumbuhan 
dan kesehatan anak. Vitamin A dan besi adalah zat gizi yang penting untuk pertumbuhan 
janin serta pertumbuhan, imunitas, dan perkembangan bayi. Vitamin A berperanan dalam 
metabolisme besi dan telah dibuktikan dapat menurunkan anemia pada ibu hamil yang 
kekurangan vitamin A. Di Indonesia, separuh dari ibu hamil menderita anemia defisiensi 
besi sedangkan sepertiga dari ibu hamil dan menyusui menderita defisiensi vitamin A. 
Suplementasi besi selama kehamilan di Indonesia merupakan standar kebijaksanaan 
sehingga tidaklah etis untuk melaksanakan penelitian yang ibu-ibu hamilnya tidak diberi 
tablet besi. Akan tetapi, efektivitas program suplementasi besi adalah rendah. 
Suplementasi besi secara mingguan telah diusulkan sebagai metode pilihan dalam 
pemberian suplemen besi. 
Tujuan dari penelitian ini adalah untuk mengetahui apakah suplementasi mingguan 
dengan besi dan vitamin A pada ibu-ibu hamil meningkatkan pertumbuhan dan 
kesehatan, yang diindikasikan dengan penurunan kesakitan dan peningkatan 
perkembangan mental dan psikomotor, pada bayi-bayi yang dilahirkan. Hasil suplementasi 
besi dan vitamin A terhadap status gizi ibu-ibu hamil dan menyusui ditampilkan dalam 
tesis yang berjudul 'Nutrition of Indonesian women during pregnancy and lactation: 
a focus on vitamin A and iron' oleh Ski Muslimatun. 
Dari bulan November 1997 hingga November 1999, telah dilaksanakan penelitian 
pada masyarakat di 9 desa di kecamatan Leuwiliang, kabupaten Bogor, Jawa Barat, 
Indonesia, yang merekrut ibu-ibu berusia 17-35 tahun, pernah melahirkan <6 kali, hamil 
16-20 minggu dan mempunyai konsentrasi hemoglobin 80-140 g/L. Ibu-ibu dari 5 desa 
dibagi secara acak per orang untuk mendapatkan suplementasi buta-ganda satu kali setiap 
minggu, dalam pengawasan, mulai saat pendaftaran hingga melahirkan. Suplementasi 
terdiri dari 2 tablet yang setiap tabletnya mengandung 60 mg elemental besi dalam bentuk 
besi sulfat dan 250 ug asam folat dengan atau tanpa 2400 RE vitamin A. Subyek dari 
4 desa lain dikelompokkan ke dalam group ketiga, yang disebut sebagai group 'harian'. 
Subyek dalam group ini berpartisipasi dalam program nasional suplementasi besi dan 
mendapatkan tablet besi/asam folat dari pusat pelayanan kesehatan. Tablet besi/asam 
folat tersebut mempunyai bentuk fisik dan kandungan besi dan asam folat yang sama 
dengan tablet yang diberikan secara mingguan. Konsumsi tablet tidak diawasi. Pada 
awalnya, 366 ibu-ibu terdaftar. Bayi-bayi yang dilahirkan diikuti perkembangannya sampai 
paling tidak berumur 1 tahun. Subyek dianggap drop out bila mereka mengundurkan diri 
dari penelitian, pindah dari lokasi penelitian, melahirkan bayi kembar, bayi mati atau 
bayinya meninggal. Subyek yang tidak hadir dalam pemeriksaan tidak dianggap drop out. 
Pertarna, kami meneliti apakah suplementasi vitamin A dan besi selama kehamilan 
mempengaruhi status vitamin A dan besi pada bayi. Di Bab 2, kami menampilkan data 
bayi (n=222) yang mempunyai data biokimia darah konsentrasi hemoglobin pada umur 
~4 bulan [3.7 (1.9-6.3), rerata (kisaran)]. Bayi-bayi dalam kelompok mingguan vitamin A 
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plus besi mempunyai konsentrasi retinol yang lebih tinggi secara bermakna daripada bayi-
bayi dalam kelompok mingguan besi (0.62 ± 0.02 versus 0.54 ± 0.02 umol/L, rerata 
± galat baku). Konsentrasi serum retinol tidak berbeda antara kelompok mingguan besi 
dan kelompok 'harian'. Pada semua kelompok, lebih dari 70% bayi-bayi mempunyai 
konsentrasi serum retinol <0.70 umol/L. Semua kelompok mempunyai status besi yang 
tidak berbeda secara bermakna. Proporsi bayi-bayi yang mempunyai konsentrasi 
hemoglobin <100 g /L sebanyak 29%, sementara hanya ada 3 bayi yang mempunyai 
konsentrasi serum ferritin <12 ug/L. Status besi pada bayi dalam kelompok 'harian' yang 
ibunya minum <50 tablet besi selama kehamilan tidak berbeda dari kelompok yang 
minum >50 tablet besi. Konsentrasi serum retinol pada bayi berhubungan dengan 
konsentrasi serum retinol pada ibu-ibu ~4 bulan pasca melahirkan pada semua kelompok 
(r =0.374, P <0.01) dan pada saat awal kehamilan di kelompok mingguan besi dan 
kelompok 'harian'. Variabel status besi pada ibu sewaktu hamil tidak ada yang 
berhubungan dengan variabel status besi pada bayi. Konsentrasi serum retinol pada ibu 
~4 bulan pasa melahirkan, infeksi saluran pernafasan atas dan suplementasi vitamin A 
menunjukkan hubungan yang kuat dengan konsentrasi serum retinol pada bayi. 
Kedua, kami meneliti apakah suplementasi vitamin A dan besi selama kehamilan 
mempunyai dampak terhadap pertumbuhan dan kesakitan bayi hingga umur 12 bulan. 
Dalam Bab 3, kami menampilkan data bayi dalam kelompok mingguan vitamin A dan besi 
(n=107) dan mingguan besi (n=105), yang layak untuk diikuti sejak lahir, dan yang 
mengikuti pengukuran anthropometri paling tidak satu kali di Posyandu. Panjang, berat 
dan pertumbuhan, dan insiden dan prevalensi beberapa jenis penyakit bayi dalam 
kelompok yang diberi suplementasi vitamin A selama kehamilan, tidak berbeda nyata dari 
kelompok lainnya pada tiap-tiap bulan selama satu tahun pertama. Prevalensi bayi yang 
mendapat ASI (air susu ibu) dan imunisasi tidak berbeda di kedua kelompok, akan tetapi 
hanya 6.7% bayi yang mendapat imunisasi lengkap. Selama 6 bulan pertama, bayi-bayi 
yang mempunyai konsentrasi serum retinol >0.70 umol/L pertambahan berat dan 
panjang lebih banyak dan mempunyai %-score tinggi-untuk-umur lebih tinggi daripada bayi-
bayi yang mempunyai konsentrasi serum retinol <0.70 umol/L, akan tetapi mempunyai 
prevalensi kesakitan yang sama. 
Dalam Bab 4, pola pertumbuhan, faktor-faktor penentu pertumbuhan dan status gizi 
bayi dari tiga kelompok diteliti berdasarkan data dari 151 bayi laki-laki dan 167 bayi 
perempuan yang mengikuti pemeriksaan lanjutan sejak lahir. Pertambahan berat dan 
panjang sebagian besar terjadi pada usia 6 bulan pertama. Pada pemeriksaan neonatus, 
hanya 7% bayi yang stunting, 5% kurang berat, dan tidak ada yang wasting (kurang berat 
untuk tinggi). Keadaan tersebut sama pada umur 6 bulan. Pertumbuhan mulai menurun 
pada umur 6 hingga 7 bulan. Akan tetapi, pada umur 12 bulan, ada 24% bayi stunting 32% 
kurang berat, dan 4% wasting, sementara di sub kelompok yang diikuti hingga umur 
15 bulan, angka tersebut lebih tinggi. Bayi laki-laki mepunyai berat dan panjang yang lebih 
tinggi dari pada bayi-bayi perempuan dari umur 0 hingga 15 bulan, meskipun status gizi 
(%-score) tidak berbeda secara bermakna. Selama satu bulan pertama, 80% bayi 
mendapatkan ASI ekslusif, tetapi asupan makanan tambahan meningkat bersamaan 
dengan bertambahnya usia. Hampir semua ibu tetap menyusui bayi mereka selama 
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penelitian. Pilek, panas dan batuk, yang merupakan gejala penyakit yang paling sering 
dilaporkan, berhubungan secara bermakna dengan penambahan berat dan %-score yang 
lebih rendah. Konsumsi kelompok makanan hewani, buah-buahan dan biskuit 
berhubungan bermakna dengan penambahan berat dan panjang dan %-score yang lebih 
tinggi. Pola makan seperti makanan 'prelacteal', pembuangan sebagian kolostrum, atau ASI 
eksklusif >4 bulan tidak berhubungan dengan pertumbuhan atau status gizi. Dalam 
regresi linier ganda, berat dan panjang neonatus sebagai faktor yang berperanan sebelum 
kelahiran, merupakan faktor penentu yang kuat dalam pertumbuhan dan status gizi pada 
bayi usia 12 bulan. Selain itu, berat dan tinggi ibu ~18 minggu kehamilan, jenis rumah, 
dan variabel sesudah kelahiran seperti asupan makanan tertentu dan penyakit merupakan 
faktor penentu pertumbuhan dan status gizi bayi pada usia 12 bulan. 
Kami juga meneliti apakah suplementasi vitamin A dan besi selama kehamilan 
memperbaiki perkembangan mental dan psikomotor bayi (Bab 5). Bayi-bayi (n=276) 
diperiksa dengan menggunakan test Bayley pada usia 6 atau 12 bulan, dan kelompok umur 
ini terdistribusi secara merata diantara tiga kelompok perlakuan. Bayi-bayi yang ibunya 
diberi suplementasi besi dan vitamin A selama kehamilan mempunyai perkembangan 
mental dan psikomotor yang sama dengan bayi-bayi yang ibunya diberi suplementasi besi 
saja selama kehamilan. Selain itu, bayi-bayi yang ibunya diberi suplementasi mingguan besi 
selama kehamilan mempunyai perkembangan mental dan psikomotor yang sama dengan 
bayi-bayi yang ibunya berpartisipasi dalam program nasional suplementasi besi. Nilai 
indeks perkembangan mental berhubungan secara bermakna (P <0.05) tetapi berasosiasi 
lemah dengan umur ibu (r =-0.139) dan jumlah pemeriksaan kehamilan (r =-0.125). 
Dengan mengoreksi faktor tersebut diatas dan juga umur dan kelompok perlakuan, bayi-
bayi yang ibunya mempunyai konsentrasi serum retinol >0.70 umol/L pada saat 
menjelang melahirkan mempunyai nilai indeks perkembangan mental yang lebih tinggi 
dari pada bayi-bayi yang ibunya mempunyai konsentrasi serum retinol <0.70 umol/L. 
Akan tetapi, tidaklah jelas apakah hal tersebut disebabkan oleh pengasuhan yang baik oleh 
ibu yang mempunyai status gizi yang lebih baik atau karena status vitamin A selama 
kehamilan itu sendiri. 
Sebagai kesimpulan, suplementasi vitamin A selama kehamilan meningkatkan status 
vitamin A pada bayi umur ~4 bulan. Perbedaan konsentrasi serum retinol pada bayi-bayi 
yang ibunya diberi suplementasi vitamin A selama kehamilan dapat terjadi karena 
perbedaan vitamin A yang disimpan selama proses pertumbuhan di dalam kandungan, 
dari perbedaan konsentrasi vitamin A di dalam ASI, atau dari kedua-duanya. Akan tetapi, 
suplementasi vitamin A tidak berdampak terhadap pertumbuhan atau kesehatan, seperti 
ditunjukkan dengan penurunan kesakitan dan peningkatan perkembangan mental dan 
psikomotor pada bayi-bayi yang dilahirkan. Berdasarkan hubungan antara status vitamin A 
dengan pertumbuhan dan tingginya prevalensi kekurangan vitamin A, penambahan 
asupan vitamin A pada bayi-bayi mungkin akan bermanfaat. Bayi-bayi yang ibunya diberi 
suplementasi mingguan besi selama kehamilan tidak berbeda dalam parameter yang telah 
disebutkan tersebut diatas dengan bayi-bayi yang ibunya berpartisipasi dalam program 
nasional suplementasi besi. Sehingga berdasarkan hasil-hasil pada bayi, tidak ada alasan 
untuk merekomendasikan satu metode adalah lebih baik dari yang lain. Pada umur 
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~4 bulan, tddak ada bayi yang menderita anemia kurang besi, akan tetapi bayi-bayi tersebut 
mungkin akan kekurangan besi sejalan dengan bertambahnya umur. Penurunan 
pertumbuhan bayi dimulai pada umur sekitar 6 bulan dan menyebabkan tingginya 
prevalensi kurang berat dan stunting pada umur 12 bulan. Faktor-faktor penentu yang 
penting dalam pertumbuhan dan status gizi bayi adalah berat dan panjang neonatus. Oleh 
karena itu, kemungkinan masa kehamilan atau awal pasca kelahiran adalah waktu yang 
tepat untuk intervensi perbaikan pertumbuhan di masa selanjutnya. Disarkan untuk 
menambahkan vitamin A dalam program kesehatan untuk ibu hamil di Indonesia. Akan 
tetapi, agar status gizi dan pertumbuhan bayi dapat dicapai secara optimal, seluruh aspek 
lingkaran kehidupan harus dipertimbangkan. 
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